Recurrent selection to alter seed phytic acid content and iron bioavailability in maize by Beavers, Alyssa Whitney
Graduate Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2014
Recurrent selection to alter seed phytic acid
content and iron bioavailability in maize
Alyssa Whitney Beavers
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/etd
Part of the Human and Clinical Nutrition Commons
This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital
Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital
Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Beavers, Alyssa Whitney, "Recurrent selection to alter seed phytic acid content and iron bioavailability in maize" (2014). Graduate
Theses and Dissertations. 13724.
https://lib.dr.iastate.edu/etd/13724
 Recurrent selection to alter seed phytic acid content 
 
and iron bioavailability in maize 
 
by 
 
Alyssa Beavers  
 
 
 
A thesis submitted to the graduate faculty 
 
in partial fulfillment of the requirements for the degree of 
 
MASTER OF SCIENCE 
 
 
Major: Molecular and Cellular Nutrition 
 
Program of Study Committee: 
Manju Reddy, Co-Major Professor 
Paul Scott, Co-Major Professor 
Kevin Schalinske 
 
 
 
 
 
 
 
 
Iowa State University 
 
Ames, Iowa 
 
2014 
 
 
 
Copyright © Alyssa Beavers, 2014. All rights reserved.
ii 
TABLE OF CONTENTS 
 
              Page 
LIST OF FIGURES .................................................................................................   iv 
LIST OF TABLES ...................................................................................................    v 
ACKNOWLEDGEMENTS ....................................................................................   vi 
ABSTRACT………………………………. .............................................................  vii 
CHAPTER 1  GENERAL INTRODUCTION ....................................................     1 
 INTRODUCTON .................................................................................................     1 
 THESIS ORGANIZATION.................................................................................     2 
 AUTHORS’ ROLES ............................................................................................     2 
 REFERENCES ....................................................................................................     3 
CHAPTER 2.  LITERATURE REVIEW ............................................................     5 
 IMPORTANCE OF IRON IN HUMANS ...........................................................     5 
  Oxygen Transport and Storage ......................................................................     5 
  Iron Transport and Storage ............................................................................     5 
  Catalytic .........................................................................................................     6 
 IRON REQUIREMENTS ....................................................................................     7 
  Absorbed Iron Requirements .........................................................................     7 
  Dietary Iron Requirements .............................................................................     9 
 IRON DEFICIENCY AND ANEMIA ................................................................   11 
  Prevalence and Causes ...................................................................................   11 
  Adverse Effects ..............................................................................................   13 
 IRON ABSORPTION ..........................................................................................   15 
 IRON HOMEOSTASIS .......................................................................................   17 
  Systemic Iron Homeostasis ............................................................................   17 
  Cellular Iron Homeostasis..............................................................................   18 
 IRON BIOAVAILABILITY ...............................................................................   19 
  Inhibitors ........................................................................................................   20 
  Enhancers .......................................................................................................   22 
 METHODS TO ASSESS IRON BIOAVAILABILITY......................................   24 
  Human .........................................................................................................   24 
  Animal .........................................................................................................   25 
  Cell Culture ....................................................................................................   27 
 STRATEGIES TO IMPROVE IRON STATUS .................................................   27 
  Supplementation ............................................................................................   27 
iii 
  Fortification....................................................................................................   28 
  Biofortification ...............................................................................................   29 
 LPA MAIZE ........................................................................................................   34 
  Iron Bioavailability of lpa Maize ...................................................................   37 
  Recurrent Selection ........................................................................................   37 
 SUMMARY .........................................................................................................   38 
 REFERENCES ....................................................................................................   39 
 
CHAPTER 3.  RECURRENT SELECTION TO ALTER GRAIN PHYTIC  
 ACID CONCENTRATION AND IRON BIOAVAILABILITY ...................   51 
 ABSTRACT .........................................................................................................   51 
 INTRODUCTION ...............................................................................................   52 
 MATERIALS AND METHODS .........................................................................   54 
  Breeding Strategy...........................................................................................   54 
  Measurement of Phytic Acid and Available P for Recurrent Selection .........   55 
  Evaluation of Three Cycles of Selection for High or Low Phytic Acid 
  Concentration .................................................................................................   56 
  Seed Quality Evaluation: Standard Germination and Cold Tests ..................   57  
  Iron Bioavailability ........................................................................................   58 
  Phytic Acid Analysis of Bulked Maize Samples ...........................................   61 
  Iron Analysis of Bulked Maize Samples .......................................................   61 
  Data Analysis .................................................................................................   62 
 RESULTS AND DISCUSSION ..........................................................................   62 
  Relative Phytic Acid and Available P Concentrations for Recurrent 
  Selection .........................................................................................................   62 
  Seed Quality ...................................................................................................   64 
  Iron Bioavailability, Phytate, and Iron of Bulked Maize Samples ................   65 
 CONCLUSIONS..................................................................................................   66 
 REFERENCES ....................................................................................................   72 
   
CHAPTER 4.  SUMMARY AND CONCLUSIONS ...........................................   75 
 SUMMARY .........................................................................................................   75 
 CONCLUSIONS..................................................................................................   76 
APPENDIX  IRON BIOAVAILBILITY OF MAIZE HEMOGLOBIN 
    IN A CACO-2 CELL CULTURE MODEL ..................................   77 
  
 
 
iv 
LIST OF FIGURES 
 
                                                                                                                                            Page 
 
Figure 2.1 Dietary iron uptake ..................................................................................  16 
 
Figure 2.2 Iron homeostasis regulated by hepcidin ..................................................  18 
 
Figure 2.3 Regulation of transferrin receptor and ferritin expression by IRE’s 
  and IRP’s ....................................................................................................  19 
 
Figure 3.1 Iron bioavailability of bulks ....................................................................  71 
 
v 
LIST OF TABLES 
 
                                                                                                                                  Page 
Table 2.1 The recommended nutrient intakes (RNI’s) for iron for different  
  dietary iron bioavailabilities (mg/day) .......................................................    9 
 
Table 2.2  Recommended dietary allowances (RDA’s) for iron by population  
  group  .........................................................................................................    11 
 
Table 2.3 Per capita consumption of meat from 1997-1999 .....................................  12 
 
Table 2.4 Anemia prevalence (%) in preschool-age children, pregnant women,  
  and non-pregnant women in each WHO region ........................................  13 
 
Table 2.5 Summary of lpa maize mutants ................................................................ 36 
Table 3.1 Evaluation of relative standardized phytic acid ........................................ 68 
Table 3.2  Evaluation of seed quality ........................................................................ 69 
Table 3.3 Phytic Acid and Iron content of bulked maize samples ............................ 70 
vi 
ACKNOWLEDGEMENTS 
 
I would like to thank my major professors, Dr. Manju Reddy and Dr. Paul Scott, for their 
guidance and support during the last two years.  I have learned and experienced new and 
different things from each of them that have helped prepare me for wherever life takes me.  I 
would also like to thank Dr. Kevin Schalinske for his participation on my Program of Study 
committee and review of my thesis. 
I am so thankful for the members of both the Scott and Reddy labs who have become my 
dear friends both in and out of the lab.  They have also assisted me in my research and have 
helped me succeed. 
I would like to acknowledge and thank Dr. Susana Goggi, who performed the seed 
quality analysis and wrote the first draft of that portion of the Methods section, and Dr. Adrienne 
Moran-Lauter for her assistance on this project. 
I acknowledge and thank the Biotechnology Fellowship which provided me with 
financial support during my first year, and the United States Department of Agriculture which 
provided support for myself and the project. 
 
 
vii 
ABSTRACT 
 
 Most of the phosphorus (P) in cereal grains is in the form of phytic acid, a potent 
inhibitor of iron absorption that cannot be digested by monogastric livestock or humans.  High 
phytate content in staple crops contributes to the high incidence of iron deficiency in developing 
countries.  Low phytic acid (lpa) maize mutants are seen as a potential strategy to improve iron 
bioavailability, but they have poor seed quality.  Our objective was to develop both low and high 
phytic acid maize populations using recurrent selection, and to compare agronomic qualities and 
iron bioavailability of these two types of maize, as well as compare them with lpa mutant maize.  
Three cycles of selection were carried out in two broad-based synthetic populations, BS11 and 
BS31.  Our research found that recurrent selection produced a significant difference in phytic 
acid content between the high and low BS11 populations (P<0.05), but not in the BS31 
populations (P>0.05).  The BS11LPA maize population had improved germination relative to lpa 
mutant inbred lines (13-16%, P<0.05), but had similar iron bioavailability (P>0.05).     
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CHAPTER 1 
 GENERAL INTRODUCTION 
 
Introduction 
Anemia afflicts nearly a quarter of the world’s population, 1.62 billion people, and it is 
estimated that half of anemia cases are due to iron deficiency (WHO, 2008).    Iron deficiency is 
most prevalent in women of child-bearing age, pregnant women, infants, and children (WHO, 
2008).  Child development is impacted by iron deficiency due to its increased risk during the 
crucial periods of pregnancy and early childhood.  Negative pregnancy outcomes are associated 
with maternal iron deficiency anemia (Klebanoff, et al., 1991, Scholl and Hediger, 1994, Steer, 
2000), as well as brain development in iron-deficient babies (Grantham-McGregor and Ani, 
2001, Lozoff, et al., 2006).   
Dietary iron deficiency is not caused solely by a low quantity of iron in the diet, but also 
low iron bioavailability from the diet.  Heme iron, found in animal foods, has a relatively high 
iron bioavailability when compared with nonheme iron, the only type of iron found in plant 
foods.  Non-heme iron bioavailability is inhibited by various factors found in plants, but most 
notably phytate, which is abundant in cereal grains and legumes.  Diets in developing countries 
are high in these staple crops and low in animal flesh foods, putting people in these countries at 
greatest risk of iron deficiency (WHO, 2001).   
Because of phytate’s negative effect on iron absorption, low phytic acid (lpa) mutants of 
many crops have been developed, including maize.  These mutants have a large reduction in 
phytic acid content and have been shown to have improved iron bioavailability (Mendoza, et al., 
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1998), but have poor agronomic qualities (Raboy, 2009).  An alternative method to produce 
maize low in phytic acid would be through selective breeding.  This could potentially allow for a 
reduction in seed phytic acid content, improved iron bioavailability, and no reduction in 
agronomic qualities.  The aim of this thesis was to determine if recurrent selection, a method of 
selective breeding, could produce maize with a reduction in seed phytic acid content that has 
improved iron bioavailability, without harming seed quality. 
Thesis Organization 
 This thesis consists of a literature review on the importance of iron, iron deficiency, iron 
bioavailability, biofortification, and lpa maize.  Following the literature review is a paper entitled 
“Recurrent Selection to Alter Grain Phytic Acid Concentration and Iron Bioavailability.”  This 
study examined the use of recurrent selection to alter phytic acid concentration in maize, and the 
comparison of seed quality and iron bioavailability of the resulting populations with lpa maize 
mutants.  Following that is an overall conclusion of the thesis.  The appendix contains a 
published manuscript that I am a co-author on. 
Authors’ Roles 
 Throughout the duration of my master’s degree, I worked on a number of projects not 
included in this thesis.  I performed iron bioavailability analysis on a fungal iron supplement, as 
well as assisted in conducting a human iron absorption study of this iron supplement.  I also 
assisted in a human iron absorption study that examined adaptation of iron absorption to both 
high and low phytic acid diets.  
 Chapter 3 of this thesis was the focus of my master’s work, and was a collaborative effort 
that involved the work of many people.  Dr. Susana Goggi performed the seed quality analysis 
for this project, wrote the methods for the seed quality analysis, and edited the manuscript.  Dr. 
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Adrienne Moran-Lauter performed the phytic acid analysis and available phosphorus analysis.  
Dr. Paul Scott developed the breeding program, oversaw the project, and edited the manuscript.  
Dr. Manju Reddy oversaw the iron bioavailability portion of the project and edited the 
manuscript.  My role in this project was performing the iron bioavailability work, analyzing iron 
and phytic acid content of the bulked samples, performing data analysis, and writing the 
manuscript. 
 My role in the manuscript found in the appendix of this thesis was performing the iron 
bioavailability work of the transformed corn and analyzing the data for this portion of the 
project. 
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CHAPTER 2 
 LITERATURE REVIEW  
 
Importance of Iron in Humans 
 Iron is essential for many processes within the human body.  It is most commonly known 
for its role in the oxygen-carrying protein hemoglobin, but its functions reach far beyond oxygen 
transport.  Iron is also a required co-factor in many enzymes in the body.  Iron proteins can be 
classified in a number of ways, including by function of the iron atom (Crichton, 2009).  
Functionally, they may be divided into the categories of metal storage and transport, dioxygen 
(O2) transport and storage, and catalytic (Crichton, 2009).  The catalytic proteins can be 
subdivided by structure: heme, iron-sulfur, and nonheme/non-iron-sulfur.  
Oxygen Transport and Storage 
 Iron transports and stores O2 as part of the cofactor of the proteins hemoglobin and 
myoglobin.  Nearly two-thirds of the body’s iron is in hemoglobin (Pollycove and Mortimer, 
1961), so named because it consists of a globin protein portion and heme, a protoporphyrin ring 
with a ferrous iron atom (Fe2+) at the center.  This red blood cell protein carries O2 to all tissues 
of the body.  In skeletal muscle, O2 is transferred from hemoglobin to myoglobin, also a 
hemoprotein. Myoglobin temporarily stores O2, and shuttles it to the mitochondria to be utilized 
in the electron transport chain (Kamga, et al., 2012).   
Iron Transport and Storage 
 Iron storage and transport are carried out by ferritin and transferrin, respectively.  
Transferrin is capable of binding two atoms of ferric iron, Fe3+, and is responsible for carrying 
absorbed iron from the intestine to the liver via the blood stream.  In the liver, excess iron is 
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stored in ferritin in its ferrous form, Fe2+.  The ferritin protein is essentially a hollow shell that 
can be filled with 2500-3000 atoms of Fe2+.  When this stored iron is needed by the body, iron is 
transferred from ferritin back to transferrin, which transfers it to its target location, again via the 
bloodstream (Jin and Crichton, 1987).  These two proteins maintain iron homeostasis under 
direction of the peptide hormone hepcidin, the key regulator of iron status (Ganz, 2013).  Iron 
homeostasis is described in detail in a later section. 
Catalytic 
 The remaining iron proteins are enzymes in which iron plays a catalytic role.  They can 
be subdivided by their structure into hemoenzymes, iron-sulfur enzymes, and nonheme/non-iron-
sulfur enzymes. 
Hemoenzymes 
Enzymes containing a heme group are referred to as hemoenzymes (Crichton, 2009).  
Cytochrome oxidase is a well-known hemoenzyme because of its role in catalyzing the last step 
in the electron transport chain, the reduction of molecular oxygen to water.  Other hemoenzymes 
include catalase, which converts hydrogen peroxide to water and oxygen; myeloperoxidase, in 
plasma and neutrophils and helps in the destruction of pathogens; and thyroperoxidase which is 
necessary for T3 and T4 production (Crichton, 2009).  A number of cytochromes are also 
hemoproteins and are involved in the electron transport chain lipid metabolism, and 
detoxification of harmful substances (Crichton, 2009). 
Iron-sulfur Proteins 
In a number of enzymes, iron and sulfur form clusters which are used as co-factors to 
transfer electrons involved in chemical reactions (Netz, et al., 2013).  These enzymes are 
involved in the TCA cycle, DNA replication and repair, amino acid metabolism, ribosome 
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function and tRNA modification, intracellular iron homeostasis and regulation, generation of the 
5’deoxyadenosyl radical from S-adenosyl methionine, and Ca2+ metabolism (Netz, et al., 2013). 
Nonheme/Non-iron-sulfur 
The last category of iron-containing catalytic proteins is nonheme/non-iron-sulfur 
containing proteins.  This group is a catch-all for proteins that do not fit into the other groups, 
and thus is quite diverse.  This group contains enzymes involved in amino acid metabolism, 
myelination of oligodendrocytes in the brain, and in neurotransmitter synthesis (Kwik-Uribe, et 
al., 2000, Yehuda and Youdim, 1989). 
Iron Requirements 
Absorbed Iron Requirements 
 Absorbed iron requirements vary depending on sex, age, and pregnancy/lactation status.  
In non-pregnant, non-lactating adults, iron requirements are equal to the amount of iron excreted.  
Iron is lost through urine and by sloughing of intestinal cells and skin, and these are considered 
basal losses, which are estimated at 14µg/kg body weight/day (Green, et al., 1968).  In addition 
to basal losses, iron lost in menstrual blood must count toward iron needs in menstruating 
women, therefore their iron needs are much higher than those of men.  Menstruating women 
require approximately 1.5-1.7 mg of absorbed iron daily (Hallberg and Rossander-Hulten, 1991, 
Hunt, et al., 2009), while men require approximately 1-1.2 mg (Green, et al., 1968, Hunt, et al., 
2009)  Requirements of post-menopausal women are similar to those of men (Hunt, et al., 2009). 
Full-term infants are born with a sizable iron store and a high hemoglobin concentration.  
They mobilize these iron sources during the first six months of life, which provide nearly all iron 
needed during this time for exclusively breastfed infants.  Breast milk provides a small amount 
of additional iron, 0.3 mg/100 mL, which is highly bioavailable and ample to meet iron needs 
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(Domellof, 2011).  After the first six months, when they are no longer exclusively breastfed, an 
average baby will need an additional 200 mg of total body iron by the time they reach 12 
months, which is equivalent to 0.1 mg/kg/day of absorbed iron (Domellof, 2011, Oski, 1993).   
For children and adolescents, iron requirements are calculated by adding what is needed 
for growth to iron losses.  The majority of the iron needed for growth goes to increases in 
hemoglobin associated with an increase in blood volume, but a small amount also goes to 
increases in tissue iron and, for children under 8, towards storage iron.  Iron needs steadily 
increase with age until they reach a peak in the early teen years at approximately 30 µg/kg body 
weight/day, twice that needed by adults.  Iron needs then begin to decrease as growth slows, until 
they reach the adult iron requirement around age 18 (National Research Council, 2001).   
During pregnancy, iron requirements must account for fetal and placental iron deposition 
and expanded blood volume of the mother. Little iron is passed into the fetus and placenta in the 
first trimester, and expansion of blood volume does not begin until the second trimester.  During 
this time the iron requirement is estimated at 1.2 mg/day, which is actually lower than the 
requirement for non-pregnant women since menstruation ceases during pregnancy (National 
Research Council, 2001).  However, during the second trimester iron needs increase drastically 
to 4.7 mg due to increased blood volume (National Research Council, 2001), and then even 
higher to 5.6 mg in the third trimester since iron is passed to the fetus during the last ten weeks 
of pregnancy (Cao and O'Brien, 2013).  During lactation, iron needs take into account basal loss 
plus iron in breast milk, which is approximately 1.2 mg/day (National Research Council, 2001).   
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Dietary Iron Recommendations  
 Not all iron that is ingested is absorbed, which must be taken into account when setting 
dietary recommendations.  In setting recommended dietary iron intakes, the WHO categorized 
diets into four iron bioavailabilities: 15%, 12%, 10%, and 5% (WHO/FAO, 2004): 
 15%: Western-type diet high in fruits and vegetables, and meat or fish 
 12%: typical Western-type diet moderate in fruits and vegetables, and meat or fish 
 10%: diets consisting mainly of starchy staples (cereals, roots, and tubers), with some 
meat, fish, and/or ascorbic acid-rich foods. 
 5%: diets consisting almost entirely of starchy staples, high in iron inhibitors, and 
negligible meat, fish, or ascorbic acid-rich foods  
In Table 2.1, iron recommendations for each level of iron bioavailability are given, based on the 
95th percentile of absorbed iron needs: 
Table 2.1 The recommended nutrient intakes (RNIs) for iron for different dietary iron 
bioavailabilities (mg/day).  From World Health Organization (2004). 
 
Group 
Age 
(years) 
Mean 
body 
weight 
(kg) 
Recommended nutrient intake (mg/day) for a 
dietary iron bioavailability of 
15% 12% 10% 5% 
Infants and children 0.5-1 9 6.2a 7.7a 9.3a 18.6a 
 1-3 13 3.9 4.8 5.8 11.6 
 4-6 19 4.2 5.3 6.3 12.6 
 7-10 28 5.9 7.4 8.9 17.8 
Males 11-14 45 9.7 12.2 14.6 29.2 
 15-17 64 12.5 15.7 18.8 37.6 
 18+ 75 9.1 11.4 13.7 27.4 
Females 11-14b 46 9.3 11.7 14.0 28.0 
 11-14 46 21.8 27.7 32.7 65.4 
 15-17 56 20.7 25.8 31.0 62.0 
 18+ 62 19.6 24.5 29.4 58.8 
Postmenopausal  62 7.5 9.4 11.3 22.6 
Lactating  62 10.0 12.5 15.0 30.0 
aBioavailability of dietary iron during this period varies greatly. 
bPre-menarche 
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 The United States also has their own set of dietary iron recommendations, called the 
recommended dietary allowances (RDA’s), based on age, sex, and physiological state 
(pregnancy and lactation).  The 97.5th percentile of absorbed iron needs are used and then 
multiplied by a bioavailability factor.  For children over one year, adolescents, and non-pregnant 
adults, these recommendations assume an iron bioavailability of 18% (National Research 
Council, 2001).  This is determined by first estimating the proportions of nonheme and heme 
iron in the American diet, 90% and 10% respectively (Raper, et al., 1984).  Bioavailability of 
heme iron was conservatively estimated to be 25% (Hallberg and Rossander-Hulten, 1991).  The 
bioavailability of nonheme iron was estimated by measuring nonheme iron bioavailability in the 
customary diets of Americans, and then correcting this value to a serum ferritin concentration of 
15 µg/mL (Cook, et al., 1991).  This resulted in an estimated nonheme iron bioavailability of 
16.8%. This leads to an overall bioavailability of iron in the American diet of approximately 
18%: 
Overall iron absorption = (Fraction of nonheme iron [0.9] x proportion of nonheme iron 
absorption [0.168]) + (Fraction of heme iron [0.1] x proportion of heme iron absorption [0.25]) × 
100 = 17.6 percent (National Research Council, 2001).  
The RDA’s for iron are included in Table 2.2: 
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Table 2.2 Recommended dietary allowances (RDA’s) for iron by population group.  From 
National Research Council (2001). 
 
 RDA (mg/day) 
Age Males Females 
0-6 months .27 (AI)* .27 (AI) 
7-12 months 11 11 
1-3 years 7 7 
4-8 years 10 10 
9-13 years 8 8 
14-18 years 11 15 
19-50 years 8 18 
51+ 8 8 
Pregnancy  27 
Lactation  9 
*Adequate intake 
Iron Deficiency and Anemia 
 Iron deficiency is defined by the WHO as “a condition in which there are no mobilizable 
iron stores and in which signs of a compromised supply of iron to tissues, including the erythron, 
are noted” (WHO, 2001).  Iron deficiency may lead to anemia, but iron deficiency can occur 
before anemia is present.  Negative consequences as a result of iron deficiency can be seen 
before clinical anemia.  Anemia can have devastating consequences such as pregnancy 
complications, decreased cognitive development of children, and reduced work productivity in 
adults (WHO, 2001). 
Prevalence and Causes 
 The worldwide prevalence of iron deficiency is difficult to measure, but it is known that 
it is the most prevalent nutrient deficiency in the world (WHO, 2001).  Serum ferritin, an 
indicator of iron storage, is currently considered an accurate marker of iron deficiency in the 
absence of inflammation (serum ferritin can become elevated during inflammatory conditions, 
even when the subject is iron deficient) (Goddard, et al., 2011).  However, serum ferritin is not 
routinely tested in developing countries because of its cost, so anemia is used as an indirect 
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measure of iron deficiency (WHO, 2001).  Anemia is characterized by hemoglobin (Hb) 
concentration below a certain threshold, dependent on age and sex.  The latest estimate of 
anemia prevalence is 1.62 billion people, or almost 25% of the world’s population (WHO, 2008).  
Anemia prevalence in different population groups is 47.4% of preschool-age children, 41.8% of 
pregnant women, 30.2% of non-pregnant women, and 12.7% of men (WHO, 2008).  Iron 
deficiency is responsible for half of anemia cases, while the other half is attributed to parasitic 
infections and deficiencies of other micronutrients (WHO, 2001).   
 The biggest risk factors for iron deficiency anemia are low intake of iron, high intake of 
inhibitors of iron absorption, and high iron needs during growth and pregnancy (WHO, 2008).  
The first and second of these risk factors are especially prevalent in developing countries where 
the rate of poverty is high.   Income has a strong positive relationship with consumption of 
animal foods, particularly meat (WHO/FAO, 2003).  The per capita meat consumption for 
different regions of the world is shown in Table 2.3.  The poorest regions of the world, including 
Sub-Saharan Africa and South Asia, have much lower meat consumption than industrialized 
countries. 
Table 2.3 Per capita consumption of meat from 1997-1999.  Adapted from WHO/FAO (2003). 
Region  Meat (kg/year) 
World 36.4 
Developing countries 25.5 
Near East and North Africa 21.2 
Sub-Saharan Africaa 9.4 
Latin America and the Caribbean 53.8 
East Asia 37.7 
South Asia 5.3 
Industrialized countries 88.2 
Transition countries 46.2 
a Excludes South Africa  
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Meat is amongst the most iron-rich foods, so low meat intake typically implies a low total intake 
of iron.  It is therefore not surprising that regions that consume the least meat also tend to have 
the highest prevalence of anemia.  In Table 2.4, anemia prevalence in different regions of the 
world is given, subdivided into population groups that are most at-risk of anemia: preschool-age 
children, pregnant women, and non-pregnant women.  It is evident that areas with the lowest 
meat consumption, Africa and South-East Asia, have the highest incidences of anemia.   
Table 2.4 Anemia prevalence (%) in preschool-age children, pregnant women, and non-pregnant 
women in each WHO region.  Adapted from WHO (2008). 
 
WHO Region Preschool-age children Pregnant women Non-pregnant women 
Africa 67.6 57.1 47.5 
Americas 29.3 24.1 17.8 
South-East Asia 65.5 48.2 45.7 
Europe 21.7 25.1 19.0 
Eastern Mediterranean 46.7 44.2 32.4 
Western Pacific 23.1 30.7 21.5 
Global 47.4 41.8 30.2 
 
In addition to having diets low in meat, people in developing countries consume over half their 
calories from cereals compared with only 30% in industrialized countries (WHO/FAO, 2003).  
Cereal grains, including rice, wheat, and maize, have high levels of inhibitors of iron absorption.   
Adverse Effects 
 Iron deficiency, both with and without anemia, has negative consequences on both 
physical and mental health.  Since the risk of iron deficiency is highest amongst pregnant women 
and children, many of the known adverse health effects are related to maternal health and child 
development.  However, non-pregnant adult women are susceptible to the effects of iron 
deficiency as well.  
 Iron deficiency during pregnancy is particularly dangerous to both the mother and the 
child.  Maternal iron deficiency anemia is associated with inadequate gestational weight gain 
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(Scholl and Hediger, 1994), preterm delivery (Klebanoff, et al., 1991), and low birth weight 
babies (Steer, 2000).  Prenatal iron supplementation has been shown to decrease these 
complications (see section on supplementation below). 
For the child, brain development is particularly impacted by maternal iron deficiency.  
Brain development begins in utero, and remains quite active during the infant and toddler years.  
Iron deficiency in this period can have lasting effects, even if iron status is corrected later.  
Animal studies have elucidated some of the manners in which iron deficiency affects brain 
development.  In rats, iron deficiency during pregnancy led to decreased brain iron in the fetuses, 
and disrupted prenatal oligodendrocyte genesis (Morath and Mayer-Proschel, 2002).  Another 
study in rats suggests that maternal iron deficiency results in damage to dopaminergic neurons in 
the offspring.  This led to behavioral impairments that lasted even after the rat pups had received 
iron supplementation and hemoglobin had normalized (Felt, et al., 2006). Studies in humans 
indicate that mental development in babies with iron deficiency anemia is lower than in iron 
replete babies (Lozoff, et al., 2006).  They also indicate that this damage is permanent, because 
behavior and development is still altered after receiving iron therapy (Grantham-McGregor and 
Ani, 2001). 
In adults, aerobic activity is negatively affected during iron deficiency.  Anemic women’s 
capacity to perform a set workout on a treadmill was lower than non-anemic women (Gardner, et 
al., 1977).  Anemia has also been shown to reduce VO2max (maximal oxygen consumption), a 
measure of aerobic capacity (Crouter, et al., 2012).  This reduced aerobic capacity results in an 
overall reduction in physical activity in people with iron deficiency, even during light activity.  A 
study of jute-factory workers (a non-strenuous job) found that anemic women were 5% less 
productive at work than their non-anemic counterparts, and performed 6.5 fewer hours of house 
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work per work (Scholz, et al., 1997).  Iron deficient women also spend more sedentary time and 
less time in light activity than non-iron deficient women (Blanton, et al., 2013). 
Cognitive and affective function are both impacted by iron deficiency in adults.  Iron 
status in women was found to be correlated with measures of cognitive executive planning 
function (Blanton, et al., 2013)  Serum ferritin was found to be lower in a group of depressed 
students than non-depressed students (Vahdat Shariatpanaahi, et al., 2007).  This could 
potentially be due to iron’s role in neurotransmitter synthesis, particularly dopamine (Bianco, et 
al., 2008) 
Iron Absorption 
 Iron is absorbed in the duodenum of the small intestine (Figure 2.1).  Heme iron, found 
only in animal foods, and nonheme iron, found in both animal and plant foods, are absorbed via 
different mechanisms.  The majority of nonheme iron is present in the ferric form, but must be 
reduced to the ferrous form prior to uptake into the enterocyte (Raja, et al., 1992).  This 
reduction is accomplished by an enzyme on the brush-border membrane of the enterocyte called 
duodenal cytochrome b (DcytB).  Ferrous iron is transported into the enterocyte by the protein 
divalent metal transporter 1 (DMT1) (Gunshin, et al., 1997).  This enzyme transports a number 
of other divalent metals into the enterocyte, including zinc and manganese.   
 Heme is transported into the enterocyte by endocytosis after binding to heme carrier 
protein 1 (HCP1).  The location of HCP1 is regulated by iron status, with the protein being found 
primarily on the apical membrane in iron deficiency, and movement to the cytoplasm in iron 
sufficient conditions (Shayeghi, et al., 2005).   Within the enterocyte, ferrous iron is cleaved 
from heme by the enzyme heme oxygenase, whose activity is increased in iron deficiency in 
order to increase the amount of iron absorbed into circulation (Raffin, et al., 1974).  
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 Within the enterocyte, ferrous iron from heme and nonheme iron sources has three 
potential fates: it can be stored as ferritin, transported across the basolateral membrane, or used 
locally by the enterocyte.  When iron status is adequate, much of it is bound to ferritin in the 
enterocyte, which prevents excess iron being absorbed (Bernier, et al., 1970). When the 
enterocytes are sloughed off, the iron in ferritin is excreted in the feces.  Iron that is needed by 
the body is transported out of the enterocyte by the transport protein ferroportin1 (Donovan, et 
al., 2000, McKie, et al., 2000).  It is then oxidized by hephaestin to Fe3+ before being transferred 
to transferrin in the blood (Vulpe, et al., 1999).   
 
Figure 2.1 Dietary iron uptake.  From Zimmerman and Hurrell (2007). 
 Both physiological and food-related factors affect iron absorption.  The strongest 
predictor of iron absorption is serum ferritin.  Serum ferritin is reflective of iron stores, with 
higher serum ferritin indicating higher iron stores.  Lower serum ferritin leads to higher 
absorption of nonheme iron (Baynes, et al., 1987).  Expression of the proteins DcytB and DMT1 
are increased in iron deficiency (Gunshin, et al., 1997, Latunde-Dada, et al., 2002), which 
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increases the amount of iron that is absorbed.  Food-related factors influencing dietary iron 
absorption are discussed later. 
Iron Homeostasis 
Systemic Iron Homeostasis 
 
When iron is adequate in the diet, iron stores remain relatively constant (Ganz, 2013).  To 
maintain iron homeostasis of the body, the small peptide hormone hepcidin is the key regulator 
(Figure 2.2).  Hepcidin expression is regulated by both body iron stores and by plasma iron 
concentration, and its expression is increased in iron sufficient conditions (Feng, et al., 2012, 
Ganz, et al., 2008).  Its mechanism of action is to bind to the iron export protein ferroportin, and 
cause its internalization and degradation, preventing iron export (Dao and Meydani, 2013).  
Ferroportin is expressed in three different types of cells: enterocytes, macrophages, and 
hepatocytes (Ganz, 2013).  In enterocytes, the internalization of ferroportin leads to the inability 
of iron within the enterocyte to be taken into the bloodstream.  The iron within the enterocyte 
will be excreted in the feces along with the enterocyte when it is sloughed off, thus hepcidin 
levels are inversely related to iron absorption (Young, et al., 2009).  Likewise, in both 
macrophages and hepatocytes iron export will not occur when hepcidin levels are high and iron 
status is adequate.  When iron status is low, hepcidin expression decreases and iron can exit cells 
via ferroportin.  Absorption of iron into bloodstream will increase, ferritin stored in the liver can 
be used to supply the rest of the body, and iron can be released from macrophages (Ganz, 2013).   
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Figure 2.2 Iron homeostasis regulated by hepcidin.  From Ganz (2013). 
Cellular Iron Homeostasis  
Although iron is necessary for life, it can create free radicals that damage cells.  Because 
of this, iron status at the cellular level is tightly regulated.  This is accomplished by iron 
regulatory proteins (IRPs), which recognize and bind iron responsive elements (IREs) .  IREs are 
hairpin loops of approximately 30 nucleotides found on the untranslated region (UTR) of mRNA 
for key proteins involved in iron metabolism, namely transferrin receptor and ferritin (Mullner 
and Kuhn, 1988, Rouault, et al., 1988).  The conformation of IRPs is regulated by cellular iron 
status.  When there is ample iron within the cells, iron forms iron-sulfur clusters on the IRPs, 
which inhibits it from binding to the IREs (Haile, et al., 1992).  When the cell is iron depleted, 
IRPs are able to bind to the IREs which regulates the mRNA at the posttranscriptional level.   
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On the transferrin receptor mRNA there are multiple IREs at the 5’ UTR.  When iron 
conditions are low, the IRPs bind to the IREs leading to increased mRNA stabilization by 
preventing degradation of the mRNA by RNases, leading to increased translation of transferrin 
receptor (Pantopoulos, 2004).  This results in cells being able to take up more transferrin-bound 
iron from circulation.  In iron replete conditions, the IRPs do not bind to the IREs of the mRNA 
and it is degraded before transferrin receptor is translated.   
On the mRNA for ferritin, there is one IRE on the 3’ UTR.  When iron conditions are 
low, IRP will bind to this IRE and prevent translation of ferritin, ensuring that iron will not be 
stored when it is needed by the cell.  When the cell is iron replete, IRP will not bind the IRE and 
ferritin will be translated.  Thus excess iron will be stored with ferritin, preventing free radical 
generation that can be caused by free intracellular iron (Pantopoulos, 2004).  Figure 2.3 depicts 
the IRP/IRE system. 
 
Figure 2.3 Regulation of transferrin receptor and ferritin expression by IREs and IRPs.  From 
Pantopoulos (2004). 
 
Iron Bioavailability 
 A commonly used definition of bioavailability is “the fraction of the ingested nutrient 
that is absorbed and subsequently used for normal physiological functions” (Fairweather-Tait 
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and Hurrell, 1996).  Bioavailability is of utmost importance in iron nutrition because of the 
number and complexity of factors that influence its absorption.  In the case of iron, 
bioavailability is further complicated because of there being two types of iron in the diet. 
 Dietary iron can be classified into two categories: heme and nonheme.  Heme iron is 
found in animal tissue foods i.e. meat, fish, and poultry.   Approximately 30-40% of iron in fish 
and pork and 50-60% in beef and chicken is heme iron, while the remainder is nonheme iron 
(Monsen, et al., 1978).  In addition to animal tissue, nonheme iron is found in highest amounts in 
grains and legumes.   
Heme iron and nonheme iron differ greatly in their bioavailability.  Heme iron has a 
bioavailability of 25-35%, and is not influenced by dietary factors (Bjorn-Rasmussen, et al., 
1974, Monsen, et al., 1978), whereas that of nonheme iron varies depending on the nutrient 
content of the whole meal.  Numerous factors have been shown to affect nonheme iron 
bioavailability, both inhibitors and enhancers.  Inhibitors include phytic acid, polyphenols, and 
calcium.  Enhancers include ascorbic acid, other organic acids, and animal protein.   
Inhibitors  
 The high presence of iron inhibitors, a form of antinutrients, in the diet is a large 
contributor to iron deficiency in developing countries.  Populations that subsist primarily on 
legumes and cereals have a high prevalence of iron deficiency because antinutrients are found in 
high concentration in these foods.     
Phytic Acid 
 Phytic acid is the most potent inhibitor of iron absorption.  It is prevalent in cereal grains, 
legumes, nuts, and to a lesser extent in green vegetables.  It chelates iron in the gut and passes 
through the body undigested (Sandberg and Andersson, 1988, Sharpe, et al., 1950).  Multiple 
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studies have shown that phytic acid inhibits nonheme iron absorption in a dose-dependent 
manner.  One study examined iron absorption from soy protein isolates, which are high in phytic 
acid (Hurrell, et al., 1992).  To examine the effects of varying native phytic acid content on iron 
absorption, phytic acid content was reduced by two methods: acid-salt or enzymatic.  Reducing 
the phytic acid content (by acid-salt) to 0.2 mg/g, 2% of the original, doubled iron absorption.  
Enzymatic phytate reduction reduced phytic acid content to virtually none (≤0.01 mg/g), and 
resulted in a fivefold increase in iron absorption.  For both the acid-salt and enzyme-treated soy 
protein isolates, adding exogenous phytic acid back to the protein isolate reduced iron absorption 
back to the original amount (Hurrell, et al., 1992).  In another study, extrinsic sodium phytate 
was added to phytic acid-free wheat rolls that were fortified with radiolabelled ferrous sulfate 
and fed to human subjects (Hallberg, et al., 1989).  Addition of only a small amount, 2 mg 
phytate P, decreased iron absorption by 18%.  Further increasing phytate P to 10 mg decreased 
iron absorption by 5%, and 250 mg phytate P decreased iron absorption by 82%.  A more 
pronounced reduction in iron absorption was seen at the lower doses of phytic acid (Hallberg, et 
al., 1989), implying that even small amounts of phytic acid are very inhibitory to iron absorption. 
Polyphenols 
 Polyphenols are a diverse class of compounds present in plant foods, including legumes, 
grains, and beverages.  They inhibit iron absorption by forming insoluble complexes with iron in 
the GI tract (Brune, et al., 1989).  Beverages that are high in polyphenols include coffee, herbal 
and black teas, and cocoa.  They are all high in a particular class of polyphenols, tannins, and 
they reduce iron absorption by 50-94% (Hurrell, et al., 1999).  In foods, many polyphenols are 
red or purple colored.  This is why colored varieties of rice and beans have lower bioavailability 
than white varieties (Glahn, et al., 2002, Tako and Glahn, 2010).  Since polyphenols are found in 
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the seed coat, seed coat removal can increase the iron bioavailability of legumes high in 
polyphenols (Ariza-Nieto, et al., 2007).  One study shows that removing polyphenols from beans 
while maintaining phytic acid, and removing phytic acid while maintaining polyphenols showed 
no improvement in iron absorption.  It was necessary to remove both polyphenols and phytic 
acid before iron absorption was improved (Petry, et al., 2010).  This implies that polyphenols and 
phytic acid do not have an additive effect on the inhibition of iron absorption. 
Calcium 
 Calcium is thought to inhibit nonheme iron bioavailability, but the results are conflicting.  
It is also is thought to be the only inhibitor of heme iron absorption (Hallberg, et al., 1993) When 
calcium and phosphate salts were given together, they decreased iron absorption in human 
subjects (Monsen and Cook, 1976).  Another study also demonstrated that addition of calcium to 
a meal as calcium salts, milk, or cheese was also shown to inhibit iron absorption by 
approximately 50% (Hallberg, et al., 1991).  However, it appears that these single-meal studies 
exaggerate the inhibitory effects of calcium on iron absorption.  Calcium was not shown to have 
an inhibitory effect on iron absorption in a complete-diet study (Reddy and Cook, 1997), nor did 
calcium supplementation for one month decrease iron bioavailability (Rios-Castillo, et al., 2014) 
Enhancers  
 While nonheme iron absorption is generally considered low, it can be markedly increased 
by the consumption of enhancers at the same time.  This is seen in the WHO’s classification of 
diets into different bioavailabilities, with overall diets assigned a higher bioavailability when 
they include enhancers of iron absorption.   
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Ascorbic Acid 
 Ascorbic acid (vitamin C) is the most effective enhancer of iron absorption (Cook and 
Monsen, 1977).  It does this by two methods: it chelates iron, keeping it soluble in the intestinal 
lumen (Conrad and Schade, 1968), and also reduces Fe3+ to Fe2+, the form that can be transported 
into the enterocyte by DMT1 (Han, et al., 1995).  Ascorbic acid increases iron absorption in a 
dose-dependent manner (Cook and Monsen, 1977).  The source of the ascorbic acid is not 
important, and it has been shown that fruit and fruit juices (Ballot, et al., 1987), vegetables 
(Hallberg, et al., 1986), and added ascorbic acid (Cook and Monsen, 1977) all enhance iron 
absorption similarly.  However, ascorbic acid must be consumed at the same time as iron to 
improve its absorption (Cook and Reddy, 2001).  
Ascorbic acid can also reverse the inhibition of iron bioavailability by phytate and 
polyphenols.  A study by Hallberg and colleagues examined the effect of adding sodium phytate 
and ascorbic acid to a meal containing white bread and butter.  The addition of 50 mg of ascorbic 
acid to a meal containing 0 mg, 25 mg, and 250 mg of phytate P increased iron absorption by 
75%, 117%, and 184% respectively.  Increasing the ascorbic acid to 100 mg further increased the 
iron absorption from meals containing 25 mg and 250 mg of phytic acid (256% and 243%, 
respectively) (Hallberg, et al., 1989) .  Another study examined the effect of adding varying 
amounts of ascorbic acid, 25 mg, 100 mg, and 500 mg, to a meal contining 420 mg of tannins.  
The iron absorption was increased 190%, 451%, and 611%, respecively, when compared to the 
meal containing tannins and no ascorbic acid (Siegenberg, et al., 1991) 
Other Organic Acids 
 Organic acids other than ascorbic acid, namely citric, lactic, malic, and tartaric, also 
improve iron bioavailability.  A study examined the iron absorption from a meal containing rice 
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and ascorbic, citric, malic, or tartaric acid, which are found in some vegetables and fruits.  All 
acids increased the amount of iron absorbed, but ascorbic acid was found to be the most potent 
(Gillooly, et al., 1983).   Lactic acid, present in some fermented foods, has also been found to 
improve iron bioavailability (Proulx and Reddy, 2007).  There is some evidence that the effect of 
organic acids on iron bioavailability can be different if the iron is in the ferrous or ferric state 
(Salovaara, et al., 2002) 
Meat, Fish, Poultry 
Animal tissue foods are a good source of highly bioavailable iron.  However, they also 
enhance nonheme iron absorption from other foods or fortification iron that are consumed at the 
same time.  This effect is similar of all animal tissues, meat, fish, and poultry (Cook and Monsen, 
1976).  Like ascorbic acid, meat can reverse the inhibition on iron bioavailability caused by 
phytic acid in cell culture (Engle-Stone, et al., 2005) and in humans (Bach Kristensen, et al., 
2005).  The mechanism by which meat enhances nonheme iron absorption is still unknown.  
There is some evidence that glycosoaminoglycans, oligosaccharides found in muscle tissue, may 
be responsible (Huh, et al., 2004).  Another study points to peptides, particularly those high in 
histidine, may be important (Swain, et al., 2002). 
Methods to Assess Iron Bioavailability 
Human   
 Human iron absorption studies are done with radioisotopes, stable isotopes, and serum 
iron curves.  In radioisotope studies, radiolabelled iron (Fe55 or Fe59) is added to food through 
either intrinsic or extrinsic tagging.  In intrinsic tagging, plants are grown hydroponically with 
radiolabelled iron added to the media, and the radiolabeled iron is incorporated into the plant 
(Layrisse, et al., 1969).  In extrinsic tagging, a small amount of radioactive iron is added to a 
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meal (Cook, et al., 1972).  It was found that isotopic exchange occurs between the radiolabelled 
iron and the iron present in food (Bjorn-Rasmussen, et al., 1972), which has resulted in reduced 
use of the intrinsic tagging technique.  Stable isotopes, Fe58 and Fe57, can also be used in intrinsic 
tagging as alternatives to radioisotopes (Fairweather-Tait and Minski, 1986, Petry, et al., 2010).  
With these methods, total blood volume is estimated (Brown, et al., 1962) and isotope 
incorporation into erythrocytes is used as a measure of iron absorption (Hosain, et al., 1962).  
This method is highly accurate for measuring bioavailability.  Disadvantages of stable isotope 
and radioisotope studies are that that they are expensive to conduct and involve exposing 
subjects to radioisotopes. 
 Serum iron curves can also be used to estimate iron bioavailability in human subjects.  In 
this method the subjects are fed a meal, and their blood is drawn at baseline and every half hour 
after consuming the meal for approximately four hours.  Serum iron is measured, change in iron 
from baseline is plotted on a curve, and the area under the curve is calculated (Conway, et al., 
2006).  The benefits of this method are that there is no need for stable isotopes or radioisotopes, 
and measuring in humans is the most accurate way to measure bioavailability.  The 
disadvantages are that, like all human studies, they are expensive to conduct, and that they 
involve repeated blood draws which are uncomfortable for the subject. 
Animal 
Numerous animal models have been used to model human iron absorption.  Rats, pigs, 
and most recently chickens, are used in iron absorption experiments, but there are benefits and 
drawbacks to each one.  Hemoglobin maintenance efficiency (HME) is generally used in 
assessing iron bioavailability in these animal models, and is determined using by the following 
equation: 
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HME=Hb Fe, mg (final)−Hb Fe, mg (initial) x 100 
Total Fe Intake, mg 
Rats are the most economical to use for experiments, but they are much less sensitive to 
iron enhancers and inhibitors than humans.  The increase in iron absorption when meat or 
ascorbic acid was added was 33 times and 12 times higher, respectively, in humans than in rats.  
Reduction in iron absorption with addition of wheat bran (high in phytic acid) was three times 
more in humans than in rats (Reddy and Cook, 1991).  This is due to the presence of 30 times 
more phytase in the rat small intestine, than is present in human small intestine (Iqbal, et al., 
1994).  Furthermore, rats are also able to increase phytase activity when fed a diet high in phytic 
acid (Lopez, et al., 2000).  This makes them a poor model to represent iron bioavailability from 
most foods (Reddy and Cook, 1991).   
A chicken model of human iron bioavailability is also used.  This model was chosen 
because of its short intestinal tract, sensitivity to mineral deficiency, and is fast-growing (Tako, 
et al., 2010).  In addition to calculating HME, expression of duodenal iron transporters (DMT1, 
DcytB, and ferroportin), and liver ferritin are measured as markers of iron status (Tako, et al., 
2011).  Because of the newness of this model, the effects of inhibitors and enhancers of iron 
bioavailability have not been determined.   
 Pigs are also used as a model for studying iron bioavailability. Their digestive physiology 
is similar to humans, they have similar nutritional requirements, and are omnivores (Patterson, et 
al., 2008).  Piglets are frequently used in iron bioavailability studies, and are made anemic by 
withholding the iron injection they typically receive at birth.   Iron bioavailability can then be 
measured by hemoglobin repletion, described above (Perks and Miller, 1996, South, et al., 2000).  
Similar responses to iron enhancers and inhibitors have been shown in pigs. Nonheme iron 
bioavailability in pigs is increased by meat (South, et al., 2000), and inability to digest phytic 
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acid is evidenced by the common addition of phytase to the diets of commercial pigs.  The 
primary disadvantage to using pigs for iron bioavailability is cost.  Since they are relatively large 
animals, they require a lot of feed and area to house them in. 
Cell Culture 
 Caco-2 cells are a fast and economical alternative to human iron absorption studies for 
studying iron bioavailability.  These cells are human colon adenocarcinoma cells that 
spontaneously differentiate in cell culture to form a monolayer similar to epithelial cells.  In iron 
uptake experiments, food first goes through in vitro digestion to simulate digestion in vivo, and 
the digesta is applied to the cells.  The first uses of this model used extrinsic labelling of the food 
with radioactive iron prior to digestion (Alvarez-Hernandez, et al., 1991, Garcia, et al., 1996).  
Iron absorption was measured by determining the amount of radioisotope that crossed through 
the Caco-2 cells to the basolateral side.  This method was later modified to eliminate the need for 
extrinsic labelling.  Instead, iron bioavailability was measured by Caco-2 cell ferritin formation.  
It was found that Caco-2 cells form ferritin in response to the amount of iron that they absorb.  
Enhancers and inhibitors of iron absorption had the same effects in Caco-2 cells as in humans 
(Glahn, et al., 1998, Glahn, et al., 2002, Yun, et al., 2004), and correlates highly to human iron 
absorption studies (Au and Reddy, 2000) 
Strategies to Improve Iron Status 
Supplementation 
 Iron supplements are typically in pill form, contain a type of inorganic iron, and are 
sometimes combined with other nutrients that are important for the target population, such as 
folic acid for pregnant women.  Supplementation is the most commonly used method to control 
iron deficiency in developing countries, and is used for both treatment and prevention (WHO, 
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2001).  The WHO recommends supplementation for all pregnant women and low-birth weight 
infants, and for children and women of child-bearing age where the prevalence of anemia is 
greater than 40% (WHO, 2001).  Iron supplementation has been shown to improve a number of 
the negative effects caused by iron deficiency.   
 Iron supplementation in anemic workers can increase work productivity.  A study on 
anemic female tea-workers in Sri Lanka found that hemoglobin, activity level, and productivity 
increased for those receiving iron supplementation (30 mg of iron as FeSO4 per day) compared 
with controls (Edgerton, et al., 1979).  Another study, of cotton mill workers in China, iron 
supplementation for twelve weeks showed an increase in hemoglobin, serum ferritin, and a 
decrease in heart rate. Production efficiency, calculated as the ratio of heart rate to energy 
expenditure, also increased (Li, et al., 1994). 
 Iron supplementation is extremely common during pregnancy, and a recent meta-analysis 
examined its effectiveness.  Iron supplementation was successful at reducing maternal iron 
deficiency and anemia, and reducing the risk of having low birth weight babies, but had no effect 
on pre-term birth or length at birth (Haider, et al., 2013).  However, negative side effects can 
occur with iron supplementation, most notably gastrointestinal.  Iron supplements can cause 
nausea, diarrhea, constipation, or black stools.  This can result in poor adherence to the 
supplementation (WHO, 2008). 
Fortification  
 Iron fortification programs exist in many countries, using a variety of foods as vehicles 
for fortification.  Staple foods are frequently fortified, such as fortification of wheat flour in the 
U.S. and U.K, and fortification of rice in the Philippines (WHO, 2001).  Condiments, particularly 
soy sauce, salt, and fish sauce are also been used (WHO/FAO, 2006).  Two recent meta-analyses 
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of fortification programs indicate that they are quite successful at reducing iron deficiency. One 
specifically examined the effect of fortification on Hb concentration of children under 10, and 
found that fortification resulted in an increase of 4.74 g/L after 6-12 month fortification 
programs (Athe, et al., 2013).   Another meta-analysis found a similar increase in Hb, 4.2 g/L, a 
40% reduction in anemia risk, and a 50% reduction in iron deficiency.  While fortification 
programs are quite successful, there are a number of challenges to implementing them, including 
collaboration of government and food industry, regulations, and choice of an iron fortificant that 
does not negatively affect sensory characteristics of the food (WHO/FAO, 2006).  Furthermore, 
fortification programs generally do not reach rural areas where commercial food is not sold 
(WHO/FAO, 2006)   
Biofortification 
 Biofortification is the improvement of nutritional traits of a staple crop with the aim of 
reducing nutrient deficiencies.  This is done by altering the genetics of the plant through selective 
plant breeding, identification of genetic mutations, or insertion of transgenes.  A number of crops 
have been targeted for iron biofortification: wheat, rice, barley, maize, millet, soy, and common 
bean (Phaseolus vulgaris).  Biofortification to reduce iron deficiency has focused on three 
characteristics of crops: increase in iron concentration, increase in iron bioavailability, and 
decrease of antinutrients such as phytic acid and polyphenols (Murgia, et al., 2012).  
Biofortification has benefits over supplementation and fortification.  Once seeds are supplied to 
farmers, biofortification can benefit rural areas that do not have access to supplements or 
fortified foods, allowing more people access to high-iron foods.  Farmers will be able to pass the 
seeds on to the next generation, creating a more self-sufficient and sustainable method of 
improving iron nutrition.  There are drawbacks to biofortification however.  Conventional plant 
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breeding can be a slow process, and changes in nutrient content of crops to levels needed is 
difficult.  When transgenic methods are used, there is a low consumer acceptability.   
High Iron Crops 
 Genetic variation in plants allows for a wide range of iron concentration within a given 
species.  In cereals this variation can be as much as 4-fold, and in legumes more than 6-fold 
(White and Broadley, 2009).  Through breeding programs, this inherent genetic variation is 
exploited to increase iron content in the commonly eaten varieties of crops.  Quantitative trait 
locus (QTL analysis) is one of the methods used to discover the genes that control iron 
concentration in crops.  This has been done in rice (Anuradha, et al., 2012), common bean (Blair 
and Izquierdo, 2012, Blair, et al., 2010), and wheat (Tiwari, et al., 2009). 
Increased crop iron concentration has been successful at increasing absorbed iron from 
some plants, including pearl millet and rice.  Iron-biofortified pearl millet, with approximately 
three times more iron than control millet, was fed to iron-deficient children in India.  Using this 
millet to prepare porridge and flatbread resulted in approximately three times more iron absorbed 
over the course of the day than the control millet (Kodkany, et al., 2013). Another study of iron-
biofortified pearl millet fed to adult women found that they absorbed twice as much iron over the 
day than control millet, but 25% less iron than fortified pearl millet (Cercamondi, et al., 2013).  
Consumption of iron-biofortified rice has shown some benefits with regards to iron status.  A 
nine month feeding trial of women in the Philippines showed that consumption of rice with a 
nearly fivefold increase in iron content resulted in a modest increase in serum ferritin and body 
iron (Haas, et al., 2005).   
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High Iron Bioavailability Crops 
 Some biofortification has focused directly on improving iron bioavailability as a 
phenotype instead of on enhancing iron concentration or decreasing antinutrients.  Iron 
bioavailability as assessed through Caco-2 cell culture was determined for a maize population, 
and used to identify quantitative trait loci (QTL), regions of DNA that are associated with a 
particular phenotype (Hoekenga, 2011).  It was found that iron concentration in maize is not 
correlated with higher iron bioavailability, but that iron bioavailability is heritable in maize.  
Quantitative trait locus (QTL) analysis found 10 QTL for iron bioavailability, but phytic acid 
was not found to be different among lines (Lung'aho, et al., 2011).  The QTL analysis was used 
to develop maize that lines that were genetically similar, but varied only in their bioavailability 
(high and low).  This maize was used in a different study to measure its iron bioavailability in 
broiler chickens and in Caco-2 cells, and determined that the maize bred to have high 
bioavailability did in fact have higher iron bioavailability in vitro and in vivo (Tako, et al., 2013).   
Transgenic Approaches 
 A number of transgenes other than phytase have been used in iron biofortification of 
staple crops.  In rice, genes involved with iron homeostasis can be altered to increase iron 
concentration from anywhere between two and six-fold (Aung, et al., 2013, Johnson, et al., 2011, 
Masuda, et al., 2013). 
 A number of crops have been transformed by the incorporation of ferritin-containing 
transgenes.  Ferritin is a protein that stores iron in plants, and is thought to a bioavailable source 
of iron (Lonnerdal, 2009).  Varieties of rice with ferritin-containing transgenes result in a 2-3.4 
increase in iron concentration (Aung, et al., 2013, Oliva, et al., 2014, Paul, et al., 2012), while 
bananas transformed with ferritin result in a 6-fold increase in iron concentration (Kumar, et al., 
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2011).  Crops have also been cotransformed with more than one transgene.  One example is the 
transformation of rice with soybean ferritin, as well as genes involved in iron homeostasis, 
resulting in rice with up to six-fold or more increase in iron concentration (Masuda, et al., 2012, 
Masuda, et al., 2013, Wirth, et al., 2009).   
Low Phytic Acid  
As mentioned previously, inhibitors of iron absorption are a major contributor to iron 
deficiency.  Reducing phytic acid content has been the major focus of biofortification to reduce 
the concentration of antinutrients in staple food crops.  Seeds of many plants, including staple 
cereal grains and legumes, store excess phosphorus by synthesizing phytic acid (myo-inositol-
1,2,3,4,5,6-hexakisphosphate or InsP6).  Approximately 75% of phosphorous in seeds is in 
phytic acid, while the remainder is inorganic phosphorous (Raboy, 2009).  Phytic acid is found in 
plants as mixed salts of minerals, primarily K, Mg, Ca, Fe, and Zn.  It is involved in many 
important processes in plants: regulation of ion flux (Lemtiri-Chlieh, et al., 2000), DNA repair, 
chromatin remodeling, RNA editing, and regulation of gene expression (Raboy, 2009). 
Phytic acid is not just a contributor to micronutrient deficiencies in humans, but also 
poses problems in animal nutrition and to the environment.  Phytic acid is not digested by 
monogastric animals, and is excreted into the feces, which can lead to water pollution in the form 
of eutrophication (Knowlton, et al., 2004).  Furthermore, the phosphorus that is part of phytic 
acid is not available to these animals.  The non-phytic acid phosphorus, available phosphorus, 
content of regular corn and soybeans is not sufficient to meet the demands of monogastric 
livestock, primarily poultry and swine.  Therefore, diets of these animals is generally 
supplemented with phosphorus or treated with phytase, enzymes that release phosphate groups 
from phytic acid to form inorganic phosphorus and lower myo-inositols.  Both phytase and 
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supplemental phosphorus add to production costs for the farmers.  Low phytic acid crops have 
the potential to ameliorate both the environmental issues caused by phytic acid and evading the 
cost associated with these feed additives because they have a molar equivalent increase in 
available phosphorus that occurs with the decrease in phytic acid content (Raboy, 2009).  Low 
phytic acid crops could prove to be versatile enough to use for both human consumption and 
livestock feed (Pfeiffer and McClafferty, 2007, Raboy, 2009). 
Most low phytic acid crops are produced through mutations of genes involved in the 
phytic acid pathways in plants.  Low phytic acid cultivars of wheat, rice, soybean, barley, 
common bean, and maize have been produced (Raboy, 2009).   Low phytic acid crops typically 
have an increase in inorganic phosphorus that is molar-equivalent to the decrease in phytic acid 
(Raboy, 2009).   The total amount of phosphorus in the seed remains roughly the same, but there 
is an increase in phosphorus that is digestible.  This phosphorus is referred to as available P since 
it is available for digestion, and is particularly important in the nutrition of monogastric 
livestock.   
Some low phytic acid crops do indeed have improved iron bioavailability, while others 
do not.  In common bean, fractional iron absorption from lpa beans with a 90% reduction in 
phytic acid was 50% higher than the wild type parent (Petry, et al., 2013).  Low phytic acid 
sorghum has improved zinc bioavailability, but not iron (Kruger, et al., 2013). 
Transgenic approaches have also been used to produce low phytic acid crops.  In these 
plants, genes for microbial phytases are inserted into the crop of interest, and they enzymatically 
reduce phytic acid content.  This approach has been used in soybean (Bilyeu, et al., 2008) to 
produce a 90% reduction in phytic acid level.  Transgenic maize over-expressing the phytase 
phyA2 from Aspergillus niger (a fungus) was produced to reduce phytic acid content.  Phytic 
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acid content was reduced by approximately 23%, and inorganic phosphorus content was 
increased by 300% in transgenic maize seeds when compared with their wild-type counterparts 
(Chen, et al., 2008).  However, some phytases may become more active when they are in 
solution, which occurs during cooking.  In another study, transgenic maize lines were produced, 
some that contained Aspergillus niger phytase (phyA), and others that contained soybean ferritin 
in addition to this phytase.  The transgenic maize did not have any less phytic acid than the non-
transgenic controls.  However, after incubating a slurry of maize and water for two hours, 30-
95% of the IP5+IP6 initially present was degraded, with the large variation dependent on maize 
line.  Iron bioavailability studies were also performed on Caco-2 cell culture.  Iron bioavailability 
was three times higher for the phytase transgenic maize than the non-transgenic control, but there 
was no further increase in iron bioavailability in the maize lines that also contained soybean 
ferritin despite an increase in iron content (Drakakaki, et al., 2005). 
LPA maize 
 Thus far, mutations in three genes have been found that can contribute to a low phytic 
acid phenotype in maize.  Therefore, low phytic acid mutants fall into three categories: lpa 1, lpa 
2, and lpa 3, with each category affecting a different gene in the phytic acid pathway (Raboy 
2009; Panzeri et al. 2011).  A summary of characteristics of these mutants is given in Table 2.5.  
There is typically a reduction in germination in these mutants, which implies that phytic acid 
performs a beneficial role in plants, including fighting oxidative stress.  In a study of one lpa 
mutant, it was found that mutants contained high incidence of oxidative stress: more free or 
weakly bound iron, higher free radical content, more carbonylated proteins, more damaged 
DNA, and less γ-tocopherol (an antioxidant) (Doria, et al., 2009). The following table gives an 
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overview of the currently known lpa mutants, their percentage reduction in phytic acid, change 
in Pi, total P, and germination.   
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Table 2.5 Summary of lpa maize mutants 
 
Study Gene  
affected 
Mutant 
name 
Reduction 
in PA 
Inorganic 
P 
Total P Germination 
affected 
Reduction 
in seed dry 
weight 
Other 
Characteristics 
Raboy, et al., 
2009 
Lpa 1 1pa1-1 66% 10-fold 
increase 
unchanged Reduced 8-23%  
Cerino Badone, 
et al., 2012 
Lpa 1 lpa1-7 88% 10-fold 
increase 
unchanged Homozygous 
is lethal 
 
N/D 
 
 
Pilu, et al., 2003 
and 2009 
Lpa 1 lpa 1-241 90% 10-fold 
increase 
unchanged 30% 
decrease 
N/D  
Shi, et al., 2007 Lpa 1 lpa 1-
mum1, -2, -
3, -4 
93% 10-fold 
increase 
unchanged Homozygous 
is lethal 
N/D Knockout 
mutants 
Raboy, et al., 
2009; Shi, et al. 
2003 
Lpa 2 lpa 2-1 50% 4-fold 
increase 
unchanged Reduced 4-16% Accumulation 
of IP4 and IP5 
Shi, et al., 2003 Lpa 2 lpa 2-2 50% 4-fold 
increase 
Unchanged Reduced N/D  
Shi, et al., 2003 Lpa 2 Zmpk-
mum1,  
-2, -3 -4 
30% 3-fold 
increase 
unchanged N/D N/D Knockout 
mutants 
Shi, et al., 2005 Lpa 3 lpa 3-1 50% 
 
6-fold 
increase 
30% 
decrease 
None 
observed 
N/D  
Shi et al., 2005 Lpa 3 lpa 3-2 50% 6-fold 
increase 
30% 
decrease 
None 
observed 
N/D  
3
6
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Iron Bioavailability of lpa Maize 
 
Iron absorption from lpa1-1 maize was measured in humans.  Tortillas were made 
with lpa1-1 and wild type maize, and were labelled via extrinsic labelling.  Blood was 
sampled two weeks after feeding, and incorporation of radiolabelled iron into red blood cells 
was measured.  Iron absorption from tortillas made with lpa maize was 49% higher than 
tortillas made with wild type maize (Mendoza, et al., 1998). A similar study was performed 
to determine if lpa maize still had better iron bioavailability after the maize was fortified with 
ferrous sulfate or sodium iron EDTA.  After fortification, there was no longer a difference in 
iron bioavailability (Mendoza, et al., 2001).   
Iron bioavailability of lpa maize transformed with soybean ferritin was also 
measured, but in Caco-2 cells.  When compared with wild-type maize, iron bioavailability of 
the non-transgenic lpa maize was increased by 50%, but this difference was not significant 
(Aluru, et al., 2011).  The lpa maize transformed with soybean ferritin had higher iron 
bioavailability than regular lpa maize, wild-type maize, and wild-type maize transformed 
with ferritin (Aluru, et al., 2011).   
Recurrent Selection 
An alternative approach to inducing mutation to create a low phytic acid phenotype is 
to selectively breed for reduced phytic acid content.  Recurrent selection uses the inherent 
quantitative genetic variation of a trait within a plant population as the starting point.  The 
desired characteristic is bred for by screening plants for a desired phenotype, and then 
intermating plants with the desired phenotypes to obtain more extreme variation in 
phenotype.  By carrying out multiple cycles of intermating, evaluating and selecting it is 
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possible to generate populations with extreme trait values.  For example, researchers at the 
University of Illinois have been selecting for protein or oil content for more than 100 years 
and the resulting populations have compositions that are the most extreme in the entire 
species (Dudley and Lambert, 2010).  It was found that a large variation in phytic acid 
content exists among different maize families, and the broad-sense heritability is high for 
phytic acid (Lorenz, et al., 2008).  Recurrent selection has been successful at breeding for 
amino acid concentration (Scott, et al., 2008), but has not yet been attempted with phytic acid 
concentration.  Using recurrent selection to breed for reduced phytic acid content could 
potentially produce a low phytic acid maize that ameliorates the problem of poor seed 
quality, and would facilitate its use in the real world setting. 
Summary 
 Iron is a vital nutrient in human health for processes such as oxygen transport and 
brain function.  However, a startlingly high number of people worldwide have iron 
deficiency, mainly children and women of childbearing age.  Low dietary iron bioavailability 
is one of the leading contributors to iron deficiency.  People in developing countries consume 
diets low in animal flesh foods, which provide highly bioavailable heme iron.  They rely 
instead on plant sources of iron which only contain nonheme iron, which has a much lower 
iron bioavailability and can be influenced by inhibitors of iron absorption.   
Phytic acid, the most potent inhibitor of iron absorption, is very high in the diets of 
people in the developing world because it is ubiquitous in legumes and cereal crops that 
make the basis of their diets.  Reducing phytic acid content in staple crops is a potential 
solution to low dietary iron bioavailability in the developing world.  It provides a more 
sustainable alternative to iron supplementation and fortification, both of which require 
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constant external inputs and oftentimes are not able to reach the people who most need them.  
Altering the phytic acid content of staple crops is more sustainable because the seeds need 
only be initially supplied to the farmers, and then they can be passed on to future generations   
The current low phytic acid crops in maize are lpa mutants.  They have a 30-90% 
reduction in phytic acid content and improved iron bioavailability.  However, they have a 
reduction in seed quality which makes them impractical to farmers.  Recurrent selection, 
selectively breeding for extremes of a given trait over many cycles, could be used as an 
alternative method to produce low phytic acid maize without diminishing seed quality. 
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Abstract 
 Most of the phosphorus (P) in cereal grains is in the form of phytic acid, a potent 
inhibitor of iron absorption that cannot be digested by monogastric livestock or humans.  
High phytate content in staple crops contributes to the high incidence of iron deficiency in 
developing countries.  Low phytic acid (lpa) maize mutants are seen as a potential strategy to 
improve iron bioavailability, but they have poor seed quality.  Our objective was to develop 
both low and high phytic acid maize populations  using recurrent selection, and to determine 
if low phytic acid maize developed through this method has improved seed quality and iron 
bioavailability when compared to lpa mutant maize.  Three cycles of selection were carried 
out in two broad-based synthetic populations, BS11 and BS31.  Our research found that 
recurrent selection produced a significant difference in phytic acid content between the high 
and low BS11 populations (P<0.05), but not in the BS31 populations (P>0.05).  The 
BS11LPA maize population had improved seed germination relative to lpa mutant inbred 
lines (13-16%, P<0.05), and similar iron bioavailability (P>0.05).     
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Introduction 
 Phytic acid, myo-inositol-1,2,3,4,5,6-hexakisphosphate or InsP6, is the most abundant 
phosphate in seeds (Bewley and Black, 1994).  Its primary function in the seed is as a storage 
molecule for phosphorus (P); and greater than 75% of P in seeds is found as part of phytic 
acid (Raboy, 2009).  Phytic acid in seeds is found as phytate, a mixed salt of phytic acid 
complexed with cations, including K, Mg, Ca, Zn, and Fe, and often associated with proteins. 
 Phytate cannot be digested by monogastric livestock species including swine and 
poultry, and as a result it passes undigested into the feces of these animals (Cromwell and 
Coffey, 1991).  This causes environmental problems when run-off from livestock operations 
leads to eutrophication of waterways (Bouwman, et al., 2011).  Phytate P is non-available to 
these animals, meaning it cannot be absorbed and utilized.  The remainder of the P in these 
seeds, not bound to phytate, is referred to as available P because it has a relatively high 
bioavailability in livestock (National Research Council, 2012).  The available P present in 
cereals and legumes is not enough for optimal animal growth, and thus P is either 
supplemented in the diets of these animals or phytase enzymes are added to the feed to break 
down phytic acid (Knowlton, et al., 2004).  Both add to feed costs, and supplementing P in 
the diet does not reduce the environmental hazard of phytate run-off from animal feces. 
Like other monogastric animals, humans do not produce significant quantities of 
phytase (Iqbal, et al., 1994).  There is some evidence that the human gut microflora can 
produce phytases, but the evidence is not strong (Markiewicz, et al., 2013).  While P 
deficiency is not of concern to humans, high phytate consumption contributes to deficiencies 
of microminerals, particularly iron.  Iron absorption is strongly inhibited by phytate, which is 
one of the predominant reasons that iron deficiency is so prominent in developing countries 
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where diets consist primarily of staple cereal crops that are rich in phytic acid (World Health 
Organization, 2001).   
Human iron absorption studies have examined the effects of adding varying amounts 
of phytate, as pure sodium phytate or as part of bran, on iron bioavailability.  In one study, 
addition of even small amounts of sodium phytate (2 mg phytate P) added to a phytate-free 
bread meal significantly inhibited iron absorption.  The inhibitory effect of increasing 
amounts of sodium phytate resulted in a dose-dependent decrease in iron absorption  
(Hallberg, et al., 1989).  In another study, addition of phytate to bread as part of maize bran 
also showed a dose-dependent inhibition on iron absorption, with a less marked effect at low 
phytate levels (Siegenberg, et al., 1991).  In both of these studies, the meals were fortified 
with inorganic iron.  This may not be representative of how phytate affects iron naturally 
present in foods because of food-matrix effects.   
 Because of the nutritional and environmental problems caused by phytate, low phytic 
acid (lpa) mutants of cereal crops and legumes have been developed.  In maize, these 
mutants have a 30-90% reduction in phytate content, and are generally accompanied by a 
molar equivalent increase in available P.  These mutants have been shown to have beneficial 
effects on iron bioavailability, resulting in a 49% increase in iron absorption (Mendoza, et al., 
1998), and also improved P utilization in pigs (Hill, et al., 2009).  However, these mutants 
typically have a reduction in seed germination, yield, and/or dry weight, making them 
undesirable for farmers (Raboy, 2009). 
 An alternative approach to creation of maize with reduced phytate levels is through 
recurrent selection.  This method of breeding involves selecting for extremes of a given trait 
or traits over multiple cycles.  It results in progeny that have higher or lower levels of a trait 
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in a given phenotype, and has been successfully used to breed for grain composition (Dudley 
and Lambert, 2010) and grain amino acid content (Scott, et al., 2008).  The objective of our 
research was to determine if recurrent selection can be used to select for both high and low 
phytic acid content.  Our research also examined if the resulting maize populations had 
differing seed quality and iron bioavailability when compared to lpa mutants.  Seed quality in 
this study is defined as the physiological seed characteristics that allow uniform and rapid 
seedling development (seed germination) and growth under a wide range of environmental 
conditions (seed vigor). 
Materials and Methods 
Breeding Strategy  
Two broad-based synthetic maize populations were used in this study.   BS31 is 
derived from FS8B and is largely tropical in origin (Horner, 1990), while BS11 is derived 
from the Pioneer two-ear composite, a corn belt population originally designed to be prolific 
(Hallauer, 1967).  Individually harvested ears from both the BS11 and BS31 populations 
were screened for relative phytate concentration via the Wade method (described in detail 
below).  The five ears with the highest and five ears with the lowest relative phytate 
concentrations from each population were chosen and made into balanced bulks, resulting in 
four categories each containing five ears each: BS11HPA (high phytic acid), BS11LPA (low 
phytic acid), BS31HPA, and BS31LPA (BS11HPA containing the ears with the highest 
phytate concentration from the BS11 population, BS31LPA containing the ears with the 
lowest phytate concentration from the BS31 population, etc.). 
For the recurrent selection breeding, seeds from each bulk were planted in adjacent 
rows.  The resulting plants were intermated in a chain-sib mating design.  In this design, the 
55 
 
pollen from one plant (plant A) is used to pollinate the silks from another within the same 
population (plant B). The pollen from plant B is used to pollinate the silks on plant C.  This 
pattern continues, and the pollen from the last plant is used to pollinate the silks on plant A.  
A total of 50 ears were made for each of the four populations.  These ears were harvested 
individually and screened for relative phytate concentration.  The five ears with the highest 
relative phytate concentration from the BS11HPA category were made into a balanced bulk, 
as were the five ears with the lowest phytate content from the BS11LPA category, and the 
same was done for BS31HPA and BS31LPA.  These bulks are considered cycle 1 (C1).  The 
following year, the C1 bulks were planted, intermated, screened for phytate content, and 
selections made in the same way as described above.  All intermating was performed within a 
category, no intermating was done between categories.  This method was continued for three 
cycles of recurrent selection `.   
Measurement of Phytic Acid and Available P for Recurrent Selection  
Phytic acid and available P were measured using colorimetric assays modified from 
Vaintraub and Lapteva (1988) and Raboy et al. (2000) as described fully in Lorenz et al. 
(2007) using reagents obtained from Sigma-Aldrich (St. Louis, MO).  A subsample of 
approximately 50 kernels from each ear was ground into fine flour with a Stein Mill grinder.  
Ten milligrams (±.2 mg) of flour from each sample were weighed into an assigned well in a 
96-well plate.  HCl, 0.65 M, was added to each well to extract both, the phytate and inorganic 
P; the plates were shaken overnight at room temperature, then centrifuged.  The supernatant 
was transferred to each of two 96-well plates, one to measure phytate and the other to 
measure available P.  To facilitate high throughput screening, and because ranking is 
sufficient for the purpose of selection, standards were not used for either assay. 
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For phytate analysis, Wade reagent (sulfosalycylic acid, FeCl3.6 H2O, and deionized 
water) was added to the supernatant, and the absorbance at 490 nm was measured after 
incubating at room temperature.  This assay is unusual amongst colorimetric assays in that a 
lower phytic acid content is reflected by a higher absorbance.  The ears with the highest or 
lowest relative phytate concentration were chosen for HPA or LPA categories, respectively.   
For available P analysis, deionized water and available P reagent (deionized water, 
ammonium molybdate, ascorbic acid, and sulfuric acid) were added to the supernatant.   
Absorbance was read at 820 nm after incubation at room temperature.  Phytate and available 
P values were converted from absorbance to standardized values (mean 0, standard deviation 
1) prior to data analysis to facilitate interpretation.   
Evaluation of Three Cycles of Selection for High or Low Phytic Acid Concentration  
To determine the effectiveness of recurrent selection on phytate concentration,  seed 
from the individually harvested ears from C3 of recurrent selection was used.  Four of the 
individually harvested ears from each of the four categories were chosen for use in the 
evaluation experiment.  Each ear will henceforth be referred to as an entry.  An additional 
four entries consisting of inbred lpa1-1 mutants, which typically have a 66% reduction in 
phytate content compared to wild type maize from the same population (Raboy, et al., 2000), 
were also included in the experiment for comparison, two in the B73 genetic background and 
two in the Mo17 genetic background.  The entries were planted in a randomized complete 
block design with environment as a blocking factor.  Six environments were used in the 
study, three fields in 2010 and three fields in 2011.  For each entry, three self-pollinations 
were made at each environment.  At maturity, each ear was individually harvested and dried 
to approximately 150 g H2O kg
-1 fresh weight. 
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Seed Quality Evaluation: Standard Germination and Cold Tests  
 Seed for these tests was harvested by hand at physiological maturity as determined by 
black layer formation according to Hunter et al. (1991).  Ears were immediately placed in a 
single layer inside a small-scale experimental dryer (Navratil and Burris, 1982) and air-dried 
with forced air at temperatures below 35°C until the seed was at 120 g H2O kg
-1 fresh weight.  
Ears were mechanically shelled individually and 100 seeds were counted from each ear for 
both the standard germination and cold tests.  
Standard germination test 
The standard germination test was used to evaluate seed viability under ideal growing 
conditions. The tests were conducted according to the Association of Official Seed Analysts 
Rules for Testing Seeds (2010).  Each sample consisted of 100 seeds per ear, and 43-69 ears 
per maize type were tested. Samples were randomized within trays and germination carts, 
and four samples were planted in each tray.  Seeds were planted on top of two sheets of crepe 
cellulose paper media (Kimberly Clark Corp., Neenah, WI) moistened with 800 mL of tap 
water on fiberglass trays (45 cm x 66cm x 2.54 cm), and lightly pressed into the media to 
create good seed-media contact. The trays were placed inside germination carts after 
planting, and the carts were placed inside a constant 25°C walk-in germination chamber with 
alternating 4-h of light and 4-h of darkness for a total of 12-h of light d-1. Percentage of 
normal seedlings was evaluated at 7 d according to AOSA Rules for Testing Seeds (2010).  
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Cold test 
A 7-d cold test (Association of Official Seed Analysts, 2009) was used to evaluate 
seed vigor.  Samples, 45-69 per type of maize, were randomized within trays and 
germination carts, and four samples were planted in each tray. One hundred seeds per ear 
were planted on one sheet of Kimpak (Kimberly Clark Corp., Neenah, WI) watered with 
1100 mL of water pre-chilled for 24-h at 10°C on fiberglass trays (45 cm x 66cm x 2.54 cm).  
One cm of dry 80% sand:20% soil mixture was used to cover the seed and media. The trays 
were placed inside enclosed germination carts after planting, and the carts were placed inside 
a dark walk-in chamber at constant 10°C for 7-d, and then moved to a constant 25°C walk-in 
germination chamber with alternating 4-h of light and 4-h of darkness for a total of 12-h of 
light d-1. Normal seedlings (AOSA, 2010) were evaluated and recorded at 7-d after moving 
the tests to the constant 25°C walk-in germination chamber.  
Iron Bioavailability  
 Iron bioavailability was assessed for BS11HPA, BS11HPA, and lpa mutants (the 
LPA and HPA categories from the BS31 population were not assessed because there was no 
statistical difference in phytate content).  Balanced bulks from approximately 50 ears from 
the cycle three of each population were made from ground maize samples.  Each bulk was 
then ground again in a Stein Mill grinder to ensure the bulks were thoroughly mixed.  To 
measure iron bioavailability, samples were taken from the bulks and subjected to in vitro 
digestion, followed by iron uptake by Caco-2 cells.  These cells produce ferritin in response 
to iron uptake, and thus iron bioavailability is expressed as ng ferritin/mg cell protein (Glahn, 
et al., 1998). 
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In vitro digestion 
 Samples and positive control were subjected to in vitro digestion as per Proulx and 
Reddy (2007) and modified as follows.  All reagents used for in vitro digestion were 
purchased from Sigma-Aldrich.   Ten mL of 0.01 M HCl was added to 1.75 g of maize flour 
along with 8.5 µmole ascorbic acid in 0.01 M HCl to increase iron uptake response to 
detectable levels (Bodnar, et al., 2013).  HCl was also added to a positive control consisting 
of 0.17 µmole FeSO4 in 0.01 M HCl.  The pH was adjusted to 2.0 with 1 M HCl, and then 
520 µL of pepsin solution (0.2 g 1:60,000 porcine pepsin in 0.01 M HCl) was added to 
simulate gastric digestion and the samples were shaken in a water bath at 37º C for one hour.  
The pH was then increased to 6.0 with 1 M sodium bicarbonate, and 1.3 mL of pancreatin 
and bile solution (0.05 g of 4× USP porcine pancreatin and 0.3 g of bile extract in 25 mL of 
0.1 M sodium bicarbonate) was added to simulate duodenal digestion.  The samples were 
shaken again for 15 minutes at 37 º C water bath.  The digests were centrifuged at 5,000g, the 
resultant supernatant was collected into a new tube, and then heated at 100º C for four 
minutes to deactivate digestive enzymes.   
Caco-2 Cell Iron Uptake 
 The iron uptake experiment was conducted with Caco-2 cells (American Type 
Culture Collection, Rockville, MD) as described fully in Bodnar et al. (2013).  Reagents and 
other material were obtained from Sigma-Aldrich or Gibco BRL (Grand Island, NY) unless 
otherwise mentioned.  Cells were grown in a cell culture flask, and were maintained with 
Dulbecco’s modified Eagle’s media (DMEM) with 1% v/v glutamine, 1% v/v antibiotic-
antimycotic, and 10% fetal bovine serum (FBS).  Cells were kept in an incubator at 37º C 
with 5% CO2.  Media was changed every other day, and cells were passaged into a new flask 
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when they reached 80-100% confluence.  Prior to passaging, cells were rinsed with Earle’s 
balanced salt solution (EBSS), and then treated with trypsin to detach cells from the flask.  
They were then centrifuged at 22.6g and transferred into a new flask.  For the iron uptake 
experiments, cells were seeded at passage 30-32 on collagenized 12-well Costar cell culture 
plates at a density of 5 × 104 cells/cm2.  Media continued to be changed every other day. 
 At 15 days post-seeding, the cells were used for the iron uptake experiment.  They 
were rinsed with EBSS, and were then treated with 0.5 mL serum free media (DMEM with 
1% v/v glutamine, 1% v/v antibiotic−antimycotic solution, 0.4 mg/mL hydrocortisone, 0.5 
μg/mL selenium, 3.4 μg/mL triiodothyronine (T3), 1 mmol/mL piperazine-N,N′-bis[2 
ethanesulfonic acid] (PIPES), 2 μg/mL EGF (epidermal growth factor), and 1 mg/mL insulin) 
and 0.5 mL of the digest supernatant.  Each digest was applied in duplicate in two separate 
wells on two separate cell culture plates (duplicates were averaged prior to analysis).  Two 
hours later, the cells were treated with a second aliquot of 0.5 mL serum free media and then 
incubated at 37º C with 5% CO2 for another 22 hours.  At 24 hours after the first application 
of serum free media, the media was aspirated and the cells were rinsed with EBSS.  
Deionized water (0.5 mL) was added to each well, and the cells were then lysed for ten 
seconds at 1W with a probe-type sonic dismembranator.  Cell lysate was transferred to 
microcentrifuge tubes and was lysed for an additional 10 seconds.  Microcentrifuge tubes 
were centrifuged, and the supernatant was used for protein and ferritin determination.  
Protein was measured in duplicate with the Bradford Commassie Assay (Pierce Laboratories, 
Rockford, IL) and ferritin was measured via enzyme immunoassay (Ramco, Stafford, TX).  
Iron bioavailability was assumed to be as ng ferritin produced by cells in response to 
treatment per mg cell protein (ng ferritin/mg protein).   
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Phytic Acid Analysis of Bulked Maize Samples  
 Phytic acid and content of the bulked maize samples used for iron bioavailability was 
quantified as described in detail in Proulx and Reddy (2007), modified from Oberleas (1971).  
Each bulked maize sample (BS11LPA, BS11HPA, and lpa mutant) was extracted with 2.4% 
HCl for three hours.  The samples were then centrifuged and filtered with Whatman’s # 5 
filter paper.  One mL of supernatant was mixed with 0.5 mL 0.75 M NaOH and 0.5 mL 0.1 
M Na2EDTA.  This mixture was run on a 1.5 x 30 cm ion-exchange column  with AG1-X4, 
100-200 mesh chloride form ion-exchange resin (Bio-Rad, Hercules, CA) and eluted with 0.7 
M NaCl.  The eluant was combined with H2SO4 and HNO3 and heat digested until a 
precipitate formed, which was then dissolved in water.  Phosphorus content was measured in 
a colorimetric assay with ammonium molybdate and sulfonic acid (4-amino-3-hydroxy-1-
naphthalenedisulfonic acid in 0.15 mol/L Na2SO3 and 0.92 mol/L NaHSO3) reagents.   
Phosphorus concentration was converted to phytic acid concentration based on the 
assumption that P content of phytic acid is 28.2%. 
Iron Analysis of Bulked Maize Samples 
Non-heme iron and non-protein bound iron were measured for the same bulked maize 
samples as described above.  For total nonheme iron, trichloroacetic acid (TCA) in acid 
treatment was followed by a colorimetric assay (Torrance and Bothwell, 1968).  Maize flour 
(0.5 g) was mixed with 2 mL 10% TCA/3 N HCl and incubated for 20 h at 65° C.  The 
mixture was then centrifuged at 5,000g for 15 min, and the resultant supernatant was mixed 
with 0.02% ferrozine [3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine-4’,4”-disulfonic acid sodium 
salt] in 2.05 M sodium acetate.  The mixture was incubated for 10 min and abs. was 
measured at 563 nm.  The protocol for non protein-bound iron was identical, except that the 
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digest was in water instead of HCl (Murray-Kolb, et al., 2003).  Protein-bound iron was 
estimated by subtracting non protein-bound iron from total nonheme iron.   
Data Analysis 
To evaluate the self-pollinated ears that originated from the C3 selections, one-way 
ANOVA followed by Tukey-Kramer multiple comparisons test were performed separately 
for both populations (BS11 and BS31) comparing the HPA category, LPA category and lpa 
mutants.  This was performed for phytic acid, available P, standard germination, and cold 
tests.  For the iron bioavailability results, one-way ANOVA followed by Tukey-Kramer 
multiple comparisons test performed to compare the mean ng ferritin/mg protein amongst the 
three bulks.   
Results and Discussion 
Relative Phytic Aid and Available P Concentrations for Recurrent Selection 
 The LPA and HPA selections from the BS11 population had significantly different 
relative phytic acid content from each other and from the lpa mutants (Table 3.1, P<0.001 for 
each pair). The lpa mutants were lowest, followed by the LPA group, and the HPA group had 
the highest relative phytic acid content.  Analysis of phytic acid from the ears from the BS31 
population found that the LPA group was slightly lower than the HPA group, but the 
difference was not significant.  Both groups from this population had significantly higher 
phytic acid concentration than the lpa mutants (Table 3.1, P<0.0001 for each pair).  For both 
populations, the LPA and HPA categories had significantly lower relative available P than 
the lpa mutant, but were not significantly different from each other (P<0.05, Table 3.1).   
These results show that three cycles of recurrent selection were successful at 
significantly altering phytic acid in the BS11 population, but not in the BS31 population. 
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Although the results from this portion of the study were relative and not quantitative, it is 
evident that the phytic acid concentration of the BS11LPA was much higher than the phytic 
acid concentration of the lpa mutant.  Recurrent selection is a slow process (Dudley and 
Lambert, 2010) and it will take many more cycles to determine if phytic acid concentration 
can be reduced close to the levels seen in lpa mutants.   
Our results suggest that recurrent selection for reduced phytic acid concentration does 
not impact available P.  Although in lpa mutants phosphorus is repartitioned from phytate-
bound P to available P, this may not be true for non-mutant maize, as evidenced by Lorenz et 
al. (2007, 2008).  However, in other maize families it has been shown that phytate and 
available P are typically highly positively correlated (Raboy, et al., 2001).  Therefore, it is 
possible that the change in phytic acid was just not enough to have a significant impact on 
the available P concentration.  More cycles of recurrent selection would be needed to 
determine if available P concentration will change, and in what direction, in response to a 
decrease in phytic acid content.   
What happens to available P content through more cycles of recurrent selection would 
impact the suitability of this maize for use in animal feeds.  While humans are generally at 
low risk for problems related to low phosphorus intake, the growth of livestock such as pigs 
can be limited if there is not adequate phosphorus in the diet (Zhai and Adeola, 2013).  
Therefore, if low phytate maize produced via recurrent selection does not result in increased 
available P, it would not mitigate the need for supplemental phosphorus.   
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Seed Quality Evaluation 
 For the standard germination test in the BS11 population, LPA and HPA had similar 
germination rates of 95% and 95%, respectively, which were significantly higher than the 
germination rate of the lpa mutants, 78% (Table 3.2, P<0.0001).  Similar results were found 
with BS31; both LPA and HPA had similar germination rates, 90%, which were significantly 
higher than that of the lpa mutants (Table 3.2, P<0.001).   
In the BS11 population, the cold germination of LPA was 89%, better than the lpa 
mutant’s cold germination of 76% (Table 3.2, P<0.01).  The cold germination of HPA, 86% 
had similar cold germination as both LPA and lpa (Table 3.2, P>0.05).  For the BS31 
population, LPA and HPA had better cold germination, 92%, than the lpa mutant (Table 3.2, 
P<0.0001).   
These results indicate that the recurrent selection process did not have a negative 
impact on seed quality, and that both the BS11 and BS31 LPA categories outperformed the 
lpa mutants.  No other studies have examined the impact that naturally present phytate has on 
seed quality, but there is abundant evidence that lpa mutants of maize have a substantial 
negative impact on seed quality.  Early studies on lpa 1-1 did not show a reduction in seed 
germination, but did show a reduction in yield (Ertl, et al., 1998).  However, later 
experiments demonstrated a large reduction in seed germination and stress tolerance for lpa1-
1 and 2-1 mutants  (Raboy, 2009).  There is also consistent evidence of a significant 
reduction in seed dry weight in both of these mutants, an undesirable characteristic (Raboy, 
et al., 2000, Shi, et al., 2007).  Other lpa mutants also have demonstrated negative seed 
quality.  The two mutants with the highest reduction in phytate, approximately 90%, have the 
greatest reduction in seed germination.  The lpa1-241 mutant is reported to have a 30% 
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reduction in germination (Pilu, et al., 2003) and the lpa1-7 mutation is lethal when 
homozygous (Cerino Badone, et al., 2012).  Shi et al. (2005) reported that the lpa3-1, with a 
50% reduction in phytic acid, did not demonstrate reductions in emergence under field 
conditions, but germination tests were not conducted.  The lack of an lpa mutant with good 
seed qualities gives impetus to determine if further cycles of recurrent selection can reduce 
phytate concentration without harming germination.    
Iron Bioavailability, Phytate, and Iron of Bulked Maize Samples 
After determining that the recurrent selection process resulted in significantly 
different phytate content between the HPA and LPA selections of BS11 but not BS31, only 
the BS11 population was used for the iron bioavailability experiments to compare with the 
lpa mutants.  Phytate and iron (non-heme, non-protein-bound, and protein-bound) were also 
quantitatively measured on the two selections from BS11, as well as the lpa mutants.  Phytic 
acid analysis of the bulked maize samples showed a 29% decrease in phytic acid content of 
the BS11LPA group when compared to the BS11HPA group, while the lpa mutant had 18% 
less phytic acid than the BS11LPA group (Table 3.3).   
Iron bioavailability was significantly different among the three maize samples tested.  
The mean for BS11LPA was 38% higher than for BS11HPA, and the lpa mutant was 60% 
higher than BS11HPA (P<0.05, Figure 3.1).  There was no significant difference between 
BS11LPA and the lpa mutant (P>0.05).  These results indicate that even a small reduction in 
phytic acid content can lead to a significant increase in iron bioavailability in maize. 
These results are promising for the future of low phytate crops.  In contrast to 
previous studies that suggest that phytate must be almost completely removed before an 
increase in iron bioavailability occurs (Hurrell, et al., 1992), this study suggests that iron 
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bioavailability will significantly increase with only relatively minor reductions in phytate.  
This increases the feasibility of producing low phytate maize that will have improved iron 
absorption, because recurrent selection is unlikely to reduce phytate levels to those seen in 
the lpa mutants.  More studies should be done to determine the optimal amount of phytic acid 
reduction in maize on its iron bioavailability.   
The iron analyses (Table 3.3) indicate that there is a substantial difference in the 
distribution of iron between the two BS11 categories, and the lpa mutants.  Approximately 
45% of the iron in the mutants is protein-bound, compared with 30% and 24% in the LPA 
and HPA categories, respectively.  Because of the toxicity of free iron in plants, iron is 
typically found bound to phytate or the protein ferritin (Morrissey and Guerinot, 2009).  
Therefore, in response to a reduction in phytate it would be necessary for the maize seed to 
produce more ferritin to limit the amount of free iron.   The bioavailability of ferritin is 
reported between approximately half as much as ferrous sulfate (Murray-Kolb, et al., 2003) 
and similar to ferrous sulfate (Lonnerdal, et al., 2006) in humans. A study in which lpa1-1 
maize mutants were transformed to contain the soybean ferritin gene found that iron 
bioavailability in Caco-2 cells could be doubled by the addition of the ferritin transgene.  
This study also found that nontransgenic lpa1-1 mutants have a 50% increase in ferritin when 
compared with non-mutant seeds  (Aluru, et al., 2011).  These findings suggest that ferritin in 
maize should be a bioavailable source of iron.  If the increase in non-protein-bound iron 
found in the lpa1-1 mutants is in fact ferritin-bound, we would have seen a much higher iron 
bioavailability in the lpa1-1 mutants in the present study.  More research should be 
conducted to determine if lpa1-1 mutants are in fact higher in ferritin than the BS11LPA 
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maize, or other factors that would explain why lpa1-1 did not have higher iron 
bioavailability. 
Conclusions 
 This study concludes that recurrent selection can be successful at altering grain phytic 
acid concentration in maize without negatively affecting seed quality.  Although progress 
will be slow, this process could potentially provide an alternative to lpa maize mutants that 
has improved germination and similar iron bioavailability.  This study also demonstrates that 
even small decreases in phytic acid content can significantly improve iron bioavailability.  
More studies will be needed to determine the optimal level of naturally-present phytic acid in 
maize to best affect iron bioavailability. 
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Table 3.1 Evaluation of relative standardized† phytic acid (PA) concentration and 
standardized available P concentration for the high phytic acid (HPA) and low phytic acid 
(LPA) categories of populations derived from BS11 and BS31, and lpa mutants.  For PA, a 
smaller value implies a higher PA content.  Means in the same column followed by different 
letters are statistically different (P<0.05).   
 
  Standardized PA 
Standardized 
Available P 
  BS 11 BS 31 BS 11 BS 31 
HPA -0.60a  -0.21a -0.09a -0.10a 
LPA 0.04b -0.05a -0.08a -0.07a 
lpa 1.13c 1.13b 0.48b 0.48b 
†For PA and available P, abs. at 490 and 820 nm, respectively, was converted to standardized 
data (mean of 0, standard deviation of 1).  Units are standard deviation from mean. 
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Table 3.2 Mean seed standard germination and cold test of the high phytic acid (HPA) and 
low phytic acid (LPA) categories of populations derived from BS11 and BS31, and lpa 
mutants.  The standard germination test measures germination under optimal conditions and 
cold test evaluates seed vigor under cold conditions.  Values are given as percentage of 
normal seedlings, ±SE.   
 
  Std. Germ. Test Cold Test 
  BS 11 BS 31 BS 11 BS 31 
LPA 95a†±1 90a±2 89a±3 92a±2 
HPA 95a±2 90a±2 86a,b±3 92a±3 
lpa 78b±2 78b±2 76b ±3 76b±2 
†Means within a column followed by different letters are statistically different (P<0.05).   
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Table 3.3 Phytic Acid (PA, mg/g) and Iron (µg/g) content of bulked maize samples from the 
high phytic acid (HPA) and low phytic acid (LPA) categories derived from the BS11 
population,  and lpa mutants.  Analyses were performed in duplicate. 
 
 
PA 
Nonheme 
Iron 
Non-protein 
-bound Iron 
Protein-bound 
Iron 
BS11LPA 7.8 16.1 11.2 4.9 
BS11HPA 9.0 16.4 12.4 4.0 
lpa  6.4 19.4 11.0 8.7 
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Figure 3.1 Iron bioavailability of bulks made from high phytic acid (HPA) and low 
phytic acid (LPA) categories of maize derived from the BS11 population, and lpa 
mutants expressed as ng ferritin/mg protein.  Bars with different letters are significantly 
different (P<0.05).  Error bars are ± SE.  Four digestions were performed per sample, and 
each digest was applied to two wells (values from the two wells were averaged prior to 
analysis) (n=4). 
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CHAPTER 4 
 CONCLUSIONS  
 
Summary 
 One of the main contributors to iron deficiency worldwide is low dietary iron 
bioavailability.  One of the strategies that has been employed to improve dietary iron 
bioavailability is through biofortification.  Biofortification to enhance iron bioavailability can 
include both increasing nutrients, such as iron, and also by decreasing antinutrients, such as 
phytic acid.  The current low phytic acid crops are predominantly mutants, which have a 
reduction in phytic acid and increase in iron bioavailability, but they also have poor seed 
quality making them unattractive to farmers.  Recurrent selection, breeding for extremes of a 
trait over many cycles, could be used to reduce phytic acid content. 
The study in chapter 3 of this thesis found that recurrent selection can successfully be 
used to alter seed phytic acid content in the BS11 maize population but not in the BS31 
population, however the phytic acid content of the BS11LPA population was still much 
higher than that of the lpa1-1 maize mutant populations.  Seed quality was higher in the 
BS11LPA population when compared with the lpa mutants, and iron bioavailability was 
similar between the two.   
In the appendix of this thesis, a transgenic approach was used to attempt to enhance 
iron bioavailability.  Purified maize hemoglobin expressed in bacteria was found to have 
similar iron bioavailability to bovine hemoglobin, which suggests that if it were 
overexpressed in maize that this could enhance iron bioavailability.  Overexpression of maize 
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hemoglobin was accomplished, however iron bioavailability was not improved when 
compared with untransformed maize.   
Discussion 
 The results of the study in chapter 3 conclude that selective breeding is a viable 
alternative to genetic mutation for reduction of phytic acid content in maize.  Furthermore, 
maize produced through recurrent selection can maintain a high seed quality because less 
drastic reductions in phytic acid are achieved.  Even a small reduction in phytic acid content, 
as achieved by the breeding program in this study, was able to improve iron bioavailability.  
This suggests that phytic acid reductions may not need to be as drastic as seen in the lpa 
mutants to improve iron status in iron deficient populations.   
 The results of the appendix indicate that while maize hemoglobin is as bioavailable as 
bovine hemoglobin, overexpression of this protein in maize is not adequate to impart 
increased bioavailability.  The results from this study suggest that although the protein 
portion of the hemoglobin was increased, iron was not incorporated into the protein.  Since 
maize hemoglobin is predominantly found in the non-edible portions, the maize seed may not 
have the necessary proteins to incorporate the heme into the globin portion. 
 Future research should examine the effects of more cycles of recurrent selection on 
phytic acid content and seed quality in the BS11 maize population.  If it is indeed possible to 
further reduce phytic acid content while maintaining seed quality, iron bioavailability should 
again be determined either through the use of an animal model such as pigs, or in humans.  
The studies in this thesis give hope that traditional breeding approaches may be able to avoid 
the disadvantages found in transgenic biofortification, and produce crops with higher iron 
bioavailability without risking the low consumer acceptance of transgenic crops.  
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ABSTRACT 
Maize (Zea mays) is an important staple crop in many parts of the world but has low iron 
bioavailability, in part due to its high phytate content. Hemoglobin is a form of iron that is 
highly bioavailable and its bioavailability is not inhibited by phytate. We hypothesize that 
maize hemoglobin is a highly bioavailable iron source and that biofortification of maize with 
iron can be accomplished by overexpression of maize globin in the endosperm. Maize was 
transformed with a gene construct encoding a translational fusion of maize globin and green 
fluorescent protein under transcriptional control of the maize 27 kDa gamma zein promoter. 
Iron bioavailability of maize hemoglobin produced in E. coli and of stably transformed seeds 
expressing the maize globin-GFP fusion was determined using an in vitro Caco-2 cell culture 
model. Maize flour fortified with maize hemoglobin was found to have iron bioavailability 
that is not significantly different from that of flour fortified with ferrous sulfate or bovine 
hemoglobin and that is significantly higher than unfortified flour. Transformed maize grain 
expressing maize globin was found to have similar iron bioavailability as untransformed 
seeds. These results suggest that maize globin produced in E. coli may be an effective iron 
fortificant but overexpressing maize globin in maize endosperm may not be a successful 
strategy to increase bioavailable iron content in maize.  
KEYWORDS 
biofortification, hemoglobin, iron bioavailability, transgenic maize
79 
 
 
INTRODUCTION 
Iron deficiency is the most prevalent nutrient deficiency, affecting an estimated two billion 
people worldwide1, and even mild deficiency has a wide range of negative health effects2. 
Despite a variety of efforts and international mandates to reduce iron deficiency, minimal 
progress has been made, particularly in some of the most isolated and resource-poor regions 
of the world where processing-based fortification strategies have not been effective. Iron 
deficiency is a particular challenge in areas where maize is a staple crop because its high 
phytate content causes low iron bioavailability3. Novel strategies are necessary to reduce iron 
deficiency in populations consuming maize, and biofortification may provide this novel 
approach. 
Biofortification is the development of staple crop genotypes that have improved nutritional 
qualities and is considered a cost efficient and self-perpetuating means of providing nutrients 
in staple crops4,5. There are significant challenges to overcome prior to the development of 
iron-biofortified maize. Some variation of total iron in maize grain has been found through 
evaluation of diverse maize genotypes6,7, but improvement in total iron content may not 
increase bioavailable iron unless phytate is significantly reduced8. Low phytate maize 
mutants9 can improve iron bioavailability10,11, but have low yields and other negative 
effects12, 13. Although natural variability in maize iron bioavailability14 may provide a path to 
breeding improved varieties, transgenic biofortification could provide another route. Grains 
have been engineered for improved iron in a variety of ways7. Expression of soybean ferritin 
in rice resulted in bioavailability similar to ferrous sulfate fortified rice when evaluated in a 
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rat hemoglobin repletion model15, and human lactoferrin produced in rice had bioavailability 
similar to that of ferrous sulfate in young women16. Reduction of phytate has been achieved 
in maize through expression of Aspergillus niger phytase, without the undesired agronomic 
effects seen in low-phytate mutants17. Improved iron bioavailability was also achieved with 
co-expression of fungal phytase and soybean ferritin18 and by expression of soybean ferritin 
in low phytate maize19. 
Transgenic biofortification faces its own challenges. Biotechnology that makes use of genes 
from different species may not be well accepted. A cisgenic approach, in which genes and 
genetic elements from the species of interest are used to produce a desired phenotype20, may 
be more acceptable21, particularly if there is a nutritional benefit22. Maize contains multiple 
genes that have the potential to increase total iron or iron bioavailability when overexpressed. 
One such gene encodes maize globin. Absorption of heme iron from animal sources is not 
affected by dietary factors like phytate23. Symbiotic soybean leghemoglobin was found to be 
as bioavailable as bovine hemoglobin24, indicating there is potential for other plant 
hemoglobins to be used as iron biofortificants. Additionally, iron in soybean leghemoglobin 
did not decrease in bioavailability after cooking while the iron bioavailability of ferrous 
sulfate was significantly reduced by cooking24, further indicating that plant hemoglobins may 
be useful as iron fortificants. 
The function of symbiotic plant globins is to produce an anoxic environment for nitrogen 
fixing bacteria by reversibly binding oxygen. While symbiotic plant globins are found only in 
legumes, all plants examined to date have genes coding for non-symbiotic globin proteins25, 
and these globin genes in maize have been characterized26. Non-symbiotic globins seem to 
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play a role in regulating hormone signal transduction27. They are able to reversibly bind 
oxygen and they seem to be involved with stress response28. In maize seedlings, maize globin 
mRNA levels increased in root tips under stress due to high salt or low oxygen, and 
expression of maize globin in tobacco allowed greater tolerance to submergence or salt29. 
When barley globin was overexpressed in maize tissue culture cells under low oxygen, 
nitrous oxide levels were reduced30. To our knowledge, the iron bioavailability of non-
symbiotic plant globins has not yet been determined. 
Overexpression of maize hemoglobin in maize endosperm is a potential avenue for 
development of maize with highly bioavailable iron that could circumvent the inhibitory 
effect of phytate. Endosperm is the starchy part of the maize kernel, containing carbohydrates 
and proteins that are used during germination. The endosperm is a desirable target for over-
expression of proteins for human nutrition as it is the part of the kernel that is most often 
consumed. The objective of this study is to evaluate the iron bioavailability of non-symbiotic 
maize globin expressed in maize endosperm and of maize hemoglobin expressed in E. coli. 
METHODS 
Expression vector construction 
A construct containing the Zea mays endosperm specific 27 kDa gamma zein promoter, a 
translational fusion of Zea mays globin 1 (ZmG) and green fluorescent protein (GFP) coding 
sequences, and the nos terminator, as shown in Figure 1, was used to transform maize. To 
create this construct, the pAct1IsGFP-1 plasmid31, containing the modified GFP gene 
sGFPs65T32 (Genbank accession ABB59985) and nos terminator sequence (modified from 
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Genbank accession V00087), was modified by the addition of the 27 kDa gamma zein 
promoter (Genbank accession EF061093). This promoter was previously cloned from maize 
inbred Va26, and chosen because it was shown to produce high expression of GFP in maize 
endosperm tissue33. GFP was included as a visual marker. The nos terminator was chosen 
because it has been shown to be an effective transcriptional terminator in many 
biotechnology applications. The predicted maize globin protein was not found to contain 
signal peptides with SignalP34, and no signal peptides or targeting sequences were added. 
The cDNA for maize globin 1 was obtained from the Iowa State University Expressed 
Sequence Tag Library (Genbank accession BM333948). A PCR product containing the 
coding sequence for the mature ZmG protein was amplified using Pfu polymerase 
(Stratagene, La Jolla, CA) from the ZmG cDNA. The primers were designed such that the 
PCR product included an NcoI site in conjunction with the start codon and completes an 
additional NcoI site at the end of the PCR product, just before the natural stop codon of 
ZmG, such that there are no changes in the amino acid sequence of ZmG itself but two 
additional amino acids are added at the C-terminal end of ZmG, proline and tryptophan 
(forward primer CGCCCTTCCATGGCACTCGCGGAGGCC; reverse 
CCATGGCATCGGGCTTCATCTCCC; bold nucleotides are the NcoI sites and underlined 
nucleotides are not in the coding sequence of ZmG).  
The PCR product was subcloned to pCR 2.1 Topo Vector (Invitrogen Corporation, Carlsbad, 
CA) for amplification in E. coli XL1 Blue (Stratagene, La Jolla, CA). The ZmG was 
restriction digested from pCR 2.1 by NcoI, and was inserted into the vector containing the 27 
kDa gamma zein promoter and GFP at the NcoI restriction site such that ZmG and GFP 
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formed a translational fusion product (ZmG-GFP) with GFP fused to the C-terminus of ZmG. 
The sequence of the construct was verified by DNA sequencing at the Iowa State University 
DNA facility prior to transformation.  
Plant transformation, tissue culture, and seed production 
Stable transformation by gold particle bombardment of HiII Type II callus35 was 
accomplished at the Plant Transformation Facility at Iowa State University. Callus was co-
bombarded with the globin-GFP expression vector and with a plasmid containing the bar 
gene for bialaphos resistance36. T0 callus was raised on bialaphos selective media, and 
resistant callus was screened with PCR with two primer sets for the presence of the ZmG-
GFP construct using GoTaq (Promega, Madison, WI) (forward primer 1 
CCGATCGACACCATGGCACTCGCGGAG, reverse 1 
CTTGCTCACCATGGCATCGGGCTTCATC; forward primer 2 
GATGAAGCCCGATGCCATGGTGAGCAAG, reverse 2 
CTGCAGCCGGGCGGCCGCTTTACTTG). The first primer set covered the fusion region 
between the 27 kDa gamma zein promoter and globin coding sequence to the fusion between 
globin and GFP. The second primer set covered the globin and GFP fusion region to the end 
of the GFP coding region. This approach eliminated any ambiguity that may have arisen 
from amplification of the native globin gene or 27 kDa gamma zein promoter. 
Transformed calli that were PCR positive for the gene construct were regenerated to plants in 
the Plant Transformation Facility Greenhouse, and crossed to the inbred B73 to create F1 
kernels. All subsequent plants were grown at the Iowa State University Transgenic Nursery 
in Ames, IA. Kernels from F1 events found to be positive for the transgenic protein were 
84 
 
advanced to the BC2F1 generation in 2007 by crossing to B73. In 2009 plants grown from 
seeds with visible GFP expression were crossed to three non-transgenic inbred lines: B110, 
B73, and Mo17. The ZmG-GFP kernels with the highest fluorescence were chosen for iron 
bioavailability analysis. This ear was produced by crossing the inbred B110 with a 
heterozygous BC2F1 plant containing event 73. As a control, we included an ear that 
expressed  GFP that was not fused to hemoglobin.  This line was developed by Shepherd33 
and was grown in the same nursery as the ZmG-GFP.  This allows us to rule out the 
influence of GFP on iron bioavailability. The ears chosen for analysis were segregating for 
their respective transgenes, as was expected based on their pedigrees, and kernels expressing 
the transgene were compared to kernels from the same ear that did not express the transgene.  
In this way, environmental and genetic effects were minimized. Segregation ratios and 50-
kernel mass were determined in duplicate for three randomly selected ears that were also 
from crosses of BC2F1 event 73 with B110. A chi square test was used to determine whether 
the actual segregation ratios were significantly different from the expected 50% transgene 
positive and 50% transgene negative ratio. A Student’s t-test was used to determine whether 
mass of positive and negative kernels was significantly different. 
Maize hemoglobin and antibody production 
Maize globin was expressed in E. coli, purified, and characterized as described by Smagghe 
et al.37. The protein was purified using metal affinity chromatography, resulting in a single 
band on an SDS-PAGE gel, and had a Soret/280 ratio that was characteristic of pure 
hemoglobin37. For this study, heme iron in the purified protein was confirmed with FTIR 
spectroscopy as described by Kundu et al.38.  Oxygenated hemoglobin was prepared by 
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dissolving in 20 mM Tris pH 4.8, 10 mM Dithiothreitol and the FTIR spectrum was 
determined. Carbon monoxide was blown over the sample for about 10 seconds and the 
sample was scanned again to obtain the deoxygenated hemoglobin spectrum.  The purified 
maize hemoglobin (ZmHb) was used as an antigen for polyclonal antibody production in 
rabbits (ProSci Incorporated, Poway, CA). 
Transgenic kernel screening 
Screening for transgene positive kernels consisted of visual screening (Figure 2) for GFP 
fluorescence using a Dark Reader hand lamp (Clare Chemical, Dolores, CO) followed by 
measuring fluorescence of individual visually positive kernels in a 24-well plate with a 
spectrofluorometer (Tecan, Mannedorf-Zurich, Switzerland) at 485 nm excitation and 535 
nm emission wavelengths. Fluorescence of flour for the iron bioavailability study was 
determined by placing equivalent amounts of flour from each sample into a 6-well Costar 
plate (Corning, Lowell, MA) and measuring 4 points within each well. Comparisons between 
samples were made with a Student’s t-test. 
In the F1 generation, the presence of the ZmG-GFP gene fusion product in fluorescent 
kernels was confirmed by immunoassay. Flour (50 mg) ground from positive kernels and the 
two untransformed parents (B73 and A188) was suspended in 500 uL of Lammeli buffer, 
boiled, centrifuged, and 15 uL of the supernatant was loaded on 15% SDS-PAGE gels. 
Separated proteins were then transferred to a nitrocellulose membrane, blocked overnight 
with 5% milk in Tris Buffered Saline with 0.05% Tween 20 (TBST). Membranes were 
probed for 3 h either with anti-GFP monoclonal antibody (Living Colors, Clontech, 
Mountain View, CA), or with anti-ZmHb polyclonal antibody (described above) with 
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1:25,000 dilution in 2% milk in TBST. Membranes were then probed for 1 h with 
horseradish peroxidase conjugated goat anti-rabbit or goat anti-mouse antibody, respectively, 
both diluted 1:50,000 in 2% milk in TBST. Immunoreactive bands were visualized by 
chemilluminescence.  
Iron bioavailability of maize hemoglobin produced in E. coli 
Whole seeds of the inbred maize line B73, grown at the ISU Agronomy Farm in 2009, were 
ground into fine flour with a Sorvall grinder (Thermo Fisher Scientific Inc., Waltham, MA). 
The flour was fortified with one of the following fortificants: ZmHb produced in E. coli, 
bovine hemoglobin (Sigma Aldrich, St. Louis, MO), or ferrous sulfate (Sigma Aldrich, St. 
Louis, MO). For each fortificant, 30 ppm iron by weight was added to the flour. No 
fortificant was added to the negative control flour sample. Because bioavailability of an iron 
fortificant can be affected by cooking39, and since virtually all maize for human consumption 
is cooked, the fortified corn flour was made into simple porridge by heating 3.5 g of flour 
with 10 mL of deionized water and 1mM ascorbic acid in a glass pot until stiff (about 5 
minutes). The porridge was then freeze-dried.  
Each sample was digested in duplicate as described by Glahn40 and modified by Proulx24,41. 
The freeze-dried samples were mixed with 15 mL 0.1 M HCl and adjusted to pH 2.0 with 1 
M HCl. Then, 1 mL of pepsin solution (1.2 g 1:10,000 porcine pepsin A in 10 mL 0.1 mol/L 
HCl) was added and the sample incubated for 1 h at 37°C with shaking at 500 rpm to mimic 
gastric digestion. The pH was then adjusted to 6 with 1 mol/L NaHCO3, and 5 mL of 
pancreatin and bile solution (0.05 g 4 x USP porcine pancreatin and 0.3 g bile extract in 35 
mL of 0.1 mol/L NaHCO3) was added. To mimic duodenal digestion, the samples were 
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incubated at 37°C with shaking for 15 min. The digests were then heat treated for 4 min at 
100°C to inactivate proteases, as suggested previously41, and centrifuged at 5000 x g for 10 
min and frozen prior to use.  
The iron uptake experiment was conducted as described by Proulx and Reddy41. All reagents 
for cell culture work were from Sigma Aldrich (St Louis, MO) or Gibco BRL (Grand Island, 
NY) unless otherwise mentioned. Caco-2 cells (American Type Culture Collection, 
Rockville, MD) at passage 18 were grown in a culture flask containing Dulbecco’s Modified 
Eagle’s Medium (DMEM) with 10% fetal bovine serum (FBS), 1% v/v nonessential amino 
acids and 1% v/v antibiotic-antimycotic solution. Cells were maintained at 37°C in an 
incubator with 5% CO2. Media was changed 3 times weekly. At 7 d, the cells were rinsed 
with Earle’s Balanced Salt Solution (EBSS), trypsinised to dissociate the cells, and 
centrifuged at 22.6 x g. The cells were seeded at passage 29 at a density of 5x104 cells/cm2 on 
collagenized (Type 1 Rat tail collagen) 12-well Costar cell culture plates (Corning, Lowell, 
MA).  
At 15 d post seeding, the cell monolayer was rinsed with EBSS. For cell uptake, 0.5 mL of 
serum free media and 0.5 mL of the supernatant of each digest were added to each cell 
culture well in a randomized complete block design, and incubated for 2 h. A subsequent 0.5 
mL serum free media was then added, followed by further incubation for 22 h. Serum free 
media consisted of DMEM with 1% v/v nonessential amino acids, 1% v/v antibiotic-
antimycotic solution, 0.4 mg/mL hydrocortisone, 0.5 ug/mL selenium, 3.4 μg/mL T3 
(triiodothyronine), and 1 mmol/mL PIPES (piperazine-N,N'-bis-[2-ethanesulfonic acid]), 2 
μg/mL EGF (epidermal growth factor), and 1mg/mL insulin39. After 24 h total incubation, 
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digests and media were removed by aspiration, and cells were rinsed with 1.5 mL EBSS. The 
cells were then lysed by addition of 0.5 mL deionized water to each well, and sonicated with 
a probe-type sonic dismembranator at lowest setting (< 1 W output) for 15 s.  
Protein in cell lysates was determined in duplicate with the Bradford Coomassie Assay 
(Pierce Laboratories, Rockford Illinois), and ferritin was determined by radioimmunoassay 
(Fer-Iron II, Ramco Laboratories, Stafford TX) and measured with a Cobra-II gamma 
counter with SpectraWorks software (Packard BioSciences, Meriden CT). Iron 
bioavailability was expressed as relative bioavailability (RBA) to the positive control on a 
plate-by-plate basis. Comparisons between respective transformed and untransformed maize 
were made with a Student’s t-test. 
Iron bioavailability of transformed maize kernels 
Kernels were visually separated into GFP positive and negative kernels for both ZmHb-GFP 
and GFP transformations.  A ground sample (0.25g) of each transgenic (+GFP) or 
nontransgenic (-GFP) grain was digested with 1.7µmoles of Fe with and without 34 µmoles 
of ascorbic acid (1:20 Fe:ascorbic acid), applied to cells, and iron bioavailability was 
assessed as described above.  Based on our initial results with low response without added 
iron, we added iron to all samples.  To further increase the ferritin response, ascorbic acid 
was also added to some samples.  A positive control with ferrous sulfate plus ascorbic acid 
alone and a negative control without added iron or ascorbic acid were treated identically to 
the flour samples. RBA was calculated as described above using the positive control as a 
reference. The total iron content of each sample was measured using nonheme iron assay 
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described by Proux et al.41.  FTIR spectrum was used to determine heme iron content of 
ZmHb-GFP as described above for maize hemoglobin produced in E. coli.  
 
RESULTS 
The bioavailability of iron in maize flour fortified with maize hemoglobin produced 
in E. coli: 
In order to determine the utility of maize non-symbiotic hemoglobin as an iron biofortificant, 
we examined the bioavailability of maize hemoglobin produced in E. coli (ZmHb) using a 
Caco-2 cell culture model to compare ZmHb to other fortificants. The presence of heme iron 
in ZmHb was confirmed by FTIR spectroscopy by observing the shift of the oxygenated to 
the deoxygenated hemoglobin peak (Figure 3). The size of the ZmHb protein was also 
confirmed as 18 kDa by Western blot (Figure 4), similar to the 18.3 kDa reported by 
Arechaga-Ocampo26. The iron bioavailability of maize flour fortified with ZmHb was not 
significantly different from that of flour fortified with bovine hemoglobin (BHb) or ferrous 
sulfate (FeSO4), but all three were significantly different from an unfortified maize flour 
sample (p = 0.0005), as shown in Figure 5.  While these data don’t support the hypothesis 
that hemoglobin iron is more bioavailable than non-chelated forms of iron such as ferrous 
sulfate, the observation that the iron bioavailability maize hemoglobin is similar to that of 
bovine hemoglobin and ferrous sulfate suggests that maize hemoglobin may be an effective 
plant-based source of highly bioavailable iron.   
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Production of the ZmG-GFP fusion protein in transgenic maize kernels 
We next set out to produce transgenic maize plants expressing maize globin. To facilitate 
detection of transgenic kernels, the globin coding sequence was translationally fused to GFP 
by elimination of the stop codon within the globin gene. Of 80 calli screened, 20 were PCR 
positive for both regions of the construct. In the F1, kernels from 15 events were visually 
positive for GFP, and the other 5 events were discarded. There are a number of possible 
reasons why 6 events were PCR positive but did not have visible GFP fluorescence in the F1 
generation, including transgene silencing and rearrangement of the transgene during 
bombardment or integration into the genome. Of these 15 events, 7 were selected for further 
experiments based on number of available kernels. 
Segregation ratios were determined visually for three randomly selected ears from crosses of 
event 73 in BC2F1 with the inbred line B110. Two of the three ears did not have segregation 
ratios that were significantly different from the expected 50% transgene positive and 50% 
transgene negative ratio (p = 0.2373 and 0.5859, n = 232 and 273 kernels, respectively). The 
third ear did have significant variation from the expected ratio (p = 0.0007, n = 186), with 
62.4% positive kernels. We conclude that the transgene was successfully incorporated into 
the maize genome and transmitted through meiosis. The mass of visually GFP positive and 
negative kernels from the same ear was not significantly different (p = 0.9348, n = 100 
kernels each from 3 ears, data not shown), indicating that the transgene does not cause a 
change in mass. There were significant differences in kernel mass between ears (p < 0.0001) 
that can be attributed to genetic and environmental differences between the plants that 
produced them. 
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The observation of GFP in kernels suggested that the transgene was successfully transcribed 
and translated. We next characterized the ZmG-GFP polypeptide. The predicted fusion 
protein has a molecular weight of approximately 43 kDa, with 18 kDa contributed from 
maize globin and 25 kDa contributed by GFP, and this molecular weight was confirmed by 
SDS-PAGE with immunoblot detection (Figure 4) in the 7 events that were tested. No 
proteins in either of the untransformed parental lines reacted with either the ZmG or GFP 
antibodies, suggesting that concentrations of native globin protein in maize endosperm are 
too low to detect and that there are no maize proteins similar to GFP. Representative blots 
including two of the events expressing the ZmG-GFP fusion protein are shown in Figure 4. 
Measured Fluorescence levels of ZmG-GFP and GFP alone were significantly higher 
between visually identified GFP positive and negative kernels (p < 0.0001).  However, total 
iron in ZmG-GFP positive flours was slightly higher than their non-transformed 
negativecontrols  (18.71 vs 16.25 µg/g) but the difference was not significant (p = 0.06, 
Table 1) when tested in the pooled maize flours. Although total iron content was 7% higher 
in the  ZmG-GFP maize, heme iron was undetectable. As expected, no difference in total iron 
content was found between GFP alone transformed and non-transformed  seeds.  
Iron bioavailability of transformed maize flours  
The mean ferritin values, expressed in ng ferritin/mg protein, were 242 and 287 with added 
ascorbic acid and 97 and 106 without ascorbic acid for ZmG-GFP positive, ZmG-GFP 
negative samples, respectively.  Average ferritin response (n=4) with the positive control was 
1935.1 and the negative control was 38.5 ng/mg protein.  The RBA (compared to a ferrous 
sulfate plus ascorbic acid) and iron content of the transformed and untransformed flours is 
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shown in Table 1. When tested with added ascorbic acid, the RBA was 15% lower with 
ZmG-GFP positive compared to negative control, however the difference was not significant 
(P=0.29).  A similar 9% non-significant (p=0.44) difference was found when ascorbic was 
not added to the samples.  Overall adding ascorbic acid improved iron bioavailability by 2.5-
fold and 2.7-fold in ZmG-GFP positive and negative samples, but the relative differences 
were same between positive and negative maize.  
Similar results were found when we tested the maize expressing GFP alone.  There was no 
significant difference in RBA between GFP positive and negative seeds when tested with 
(8.92 vs 6.67%) and without ascorbic acid (3.7 vs 3.05%).  The ferritin response with the 
positive control and the negative controls were similar to previous experiment,  2018 and 
35.6 ng/mg protein.  
DISCUSSION 
The objective of this study was to determine the potential of maize hemoglobin as iron 
fortificant by evaluating the iron bioavailability of maize hemoglobin expressed in E. coli 
and of non-symbiotic maize globin expressed in maize endosperm. Our results show that 
maize hemoglobin is as bioavailable as ferrous sulfate when added to flour at equal 
concentrations of iron. However, transgenic maize kernels expressing maize globin fused to 
GFP were found to have similar bioavailability as kernels from the same ear that were not 
expressing ZmG-GFP. Further studies are needed to confirm these effects across different 
transformation events and environments. 
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Maize has a significant amount of phytate, which is a potent inhibitor of iron absorption. 
Increasing total iron content may not be an effective method for improving iron nutrition, 
which may require strategies that improve iron bioavailability. The strategy of 
overexpressing ferritin received attention because plant ferritins have shown absorption as 
high as ferrous sulfate in rat models16 and in humans17. It is now understood that ferritin is 
degraded during digestion and iron associated with the protein will enter the common non-
heme iron pool, making it susceptible to phytate inhibition43. Unlike ferritin, hemoglobin has 
a unique uptake pathway and transport mechanisms44, and the heme pyrrole is protective 
against the inhibitory effects of phytate and other non-heme iron inhibitors23.  
Because globin is produced as a translational fusion on the N-terminus of GFP, the presence 
of GFP in transformed kernels suggests that globin is also present. Western blots confirm the 
presence of a fusion protein of the expected size that reacts with both GFP and ZmHb 
antibodies. GFP greatly facilitated kernel screening, and the results with ZmG-GFP 
expressing kernels could be useful for development future plant transformations 
overexpressing globin without GFP. Having GFP in the seeds may not be of concern because 
Richards et al., in a rodent feeding study showed no risk with regard to overall health or 
allergenicity with GFP45. Therefore, ZmG-GFP lines could be used to evaluate iron 
bioavailability in future animal feeding studies with little concern with GFP. However, based 
on not seeing positive results of RBA and not detecting heme iron with ZmG-GFP positive 
kernels, we speculate that GFP could have inhibited folding of globin or iron incorporation 
iron with globin.  No increase found in iron bioavailability in ZmG-GFP positive kernels 
compared to negative may be due to no increase in iron content, especially heme iron.  No 
significant difference in iron bioavailability between GFP positive and negative seeds 
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suggest that presence of GFP is not affecting bioavailability but does not rule out the 
negative effect of GFP on iron incorporation in the globin.  
Because of the ubiquitous nature of heme compounds within cells, it was assumed that the 
ferrochelatase activity required for heme pyrrole insertion into the expressed ZmHb would be 
accomplished without need of further genetic modification. Previous transgenic expression 
studies found that heme incorporation into the globin protein did not require overexpression 
of enzymes responsible for heme synthesis36. The three-dimensional structures of multiple 
plant globins have been determined to have a heme binding pocket27,46 and maize globin 
expressed in E. coli for this study was found to contain heme iron, indicating that plant 
globin could contain heme iron in vivo. However, only low concentrations of the native 
globin protein have been found in plant tissue28, and incorporation of heme iron into plant 
globin in planta has not been detected.  
Even though expression of ZmG-GFP was detected with fluorescence and confirmed with 
Western blot, we were unable to reliably detect heme, possibly due to low concentration of 
the protein in endosperm tissue. The fusion protein could not be identified on SDS-PAGE 
(not shown), suggesting that expression is low. In maize flour, chemiluminescence assay and 
FTIR spectroscopy for heme iron, and immunoprecipitation with the ZmHb antibody 
followed by measurement of total iron all had inconclusive results. Attempts to find native 
globin protein in untransformed seed and seedling tissues found no reactivity with the ZmHb 
antibody, suggesting that the native globin is not present in detectable concentrations. The 
maize globin presumed expressed in plant tissues was not detected by Western blot in roots, 
stems or leaves of 14d seedlings when exposed to 48h of oxygen reduced environment, or 
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250 mM NaCl (data not shown). These results were not entirely unexpected, as Aréchaga-
Ocampo et al. detected maize globin with Western blot in 5-7 d seedlings but found that 
levels of globin were greatly decreased in 14 d seedlings26. 
Drakakaki et al. showed that localization of recombinant proteins contributes to protein 
functionality47. While subcellular localization of the ZmG-GFP protein within the endosperm 
was not investigated in this study, it was expected to accumulate in the cytoplasm because 
signal sequences were not used. It is known that the presence of transgenic hemoglobin can 
have significant effects on plant growth and can alter concentrations of a wide variety of 
metabolites48,49. However, compartmentalization may compromise heme pyrrole 
incorporation. It is suggested that the enzymes in plants responsible for heme synthesis and 
the insertion of iron into heme pyrroles are associated with the mitochondria and 
chloroplasts50,51,52 but it is not currently clear where heme pyrrole insertion into globin takes 
place. In Arabidopsis, alfalfa, and cotton, hemoglobin is found in the cytosol and in the 
nucleus53, indicating that cytoplasmic accumulation of the protein would be sufficient for 
heme pyrrole insertion. Maize globin sequence is not predicted to have a signal sequence34. 
Still, appropriate targeting could result in higher protein expression levels, or greater heme 
pyrrole incorporation.  
This study establishes the possibility of altering iron bioavailability in maize carrying a 
transgene encoding maize hemoglobin. Important questions about the feasibility of this 
approach remain. It will be important to examine the stability of transgene expression in 
different environments and in particular to understand the impact of environmental iron 
levels on transgene expression. Further, it will be important to understand the impact of 
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accumulation of the transgene-derived globin protein on iron homeostasis in the plant. Large 
disruptions in iron homeostasis could interfere with iron-dependant metabolic processes such 
as photosynthesis and could lead to reductions in grain yield. 
Since hemoglobin expressed in E-coli has similar bioavailability as bovine hemoglobin but 
not in transformed seed, suggesting iron is not incorporated in the pyrrole ring or the pyrrole 
ring is not incorporated into the globin protein.  It is possible that endosperm cells don’t 
make sufficient amounts of pyrrole to meet the requirements of the over-expressed globin 
protein. A second consideration is that the pyrrole may not be in produced in the same 
subcellular compartment as the globin protein.  In conclusion, this study shows that 
expressing globin alone may not necessarily be useful unless we include strategies for iron 
incorporation.  Future studies are needed to perform transformations without GFP or express  
enzymes that involved iron incorporation to increase heme iron content.   
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Table 1. Iron bioavailability expressed in relative bioavailability (RBA) expressed as ferritin 
synthesis (ng ferritin /mg cell protein) in relation to a positive control (ferrous sulfate plus 
ascorbic acid), and total iron (µg/g) of maize flour of visually identified  GFP positive and 
negative maize kernels expressing  transcriptional fusion of maize globin and GFP (ZmG-
GFP) and GFP alone. Both transformed and untransformed ZmG-GFP and GFP samples 
were tested with and without ascorbic acid.  Statistical comparison was conducted with a 
Student’s t-test. 
 
RBA (%) Total iron (ug/g) 
n mean SEM p 
value 
n mean SEM p 
ZmG-GFP 
with AA 
Positive 4 12.59 1.71 
0.29 
2 18.71 0.71  
 
0.06 Negative 4 14.83 0.91 
ZmG-GFP 
without AA 
Positive 4 5.00 0.39 
0.44 
2 16.25 0.80 
Negative 4 5.51 0.50 
GFP  
with AA 
Positive 4 8.92 1.70 0.32 2 15.49 0.36  
 
0.24 
Negative 4 6.67 1.16 
GFP  
without AA 
Positive 4 3.70 0.43 0.23 2 14.09 0.68 
Negative 4 3.05 0.23 
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Figure 1. Gene construct used to create maize overexpressing maize globin. The construct 
contains the endosperm specific 27 kDa gamma zein promoter, a fusion of maize globin 
(ZmG) and green fluorescent protein (GFP) coding sequences, and the nos terminator. The 
position of the start codon ATG and the translational stop codon are located as indicated 
here. This construct is designed to result in a translational fusion product with GFP fused to 
the C-terminus of ZmG. 
  
nos 27kDa ɣ zein 
NcoI NcoI ZhoI 
ZmG GFP 
stop ATG 
99 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Kernels from a representative ear segregating for ZmG-GFP in white light (top) 
and in blue light (485 nm) with an orange filter (535 nm) (bottom). Fluorescing kernels 
appear bright yellow-green while non-fluorescing kernels appear dark or orange.  
100 
 
 
 
 
 
Figure 3. Heme iron in ZmHb produced in E. coli as detected with FTIR. Oxygenated ferric 
maize hemoglobin has a peak at 412 nm (abs 0.155) and deoxygenated  ferric maize 
hemoglobin has a peak at 418 nm (abs 0.255). 
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Figure 4. Western blots of maize endosperm using antibodies to GFP or maize hemoglobin 
(ZmHb). Lanes on both blots: 1 maize hemoglobin produced in E. coli (30 ng), 2 GFP 
standard (Clontech, Mountain View, CA) (20 ng), 3 transgenic event 26 F1, 4 transgenic 
event 65 F1, 5 untransformed A188, 6 untransformed B73. Maize hemoglobin is expected to 
be approximately 18 kDa and GFP is expected to be approximately 25 KDa, so the fusion 
protein is expected to be approximately 43 kDa. 
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Figure 5. Iron bioavailability of fortified maize flour expressed as ferritin synthesis 
(ng ferritin / mg cell protein) relative to ferrous sulfate. The iron bioavailability for bovine 
hemoglobin (BHb), maize hemoglobin (ZmHb), and ferrous sulfate (FeSO4) are not 
significantly different, but all three are significantly different from flour with no added 
fortificant (p = 0.0005, n = 8). 
 
 
 
 
 
 
 
A 
A 
A 
B 
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